President’s Report Supplement
Program Listing and View of IOM Finances
2012 EDITION
1
TABLE OF CONTENTS
Contents
Letter from the President2
Degrees of Impact11
President’s Office and Executive Office Staff
13
Recent Publications15
Program Listing19
IOM Finances63
Donors and Sponsors69
In Memoriam89
2
PRESIDENT’S REPORT SUPPLEMENT
15 October 2012
Dear Friends,
Shortly before I began my service as the Institute of Medicine (IOM) president 10 years ago, I had
an opportunity to visit with senior staff, including our deputy executive officer, Clyde Behney. I
asked Clyde, as part of my orientation, if he could confer with the board directors and put together
a list of what they deemed to be the best studies the IOM had produced to date.
“Happy to do it,” said Clyde.
A while later, he came back to the office I was using. “I have a question,” Clyde began, with a
slight smile. “What exactly do you mean by ‘best’?”
“Oh,” I replied hesitantly. “What do you mean by ‘What do you mean?’”
“Well,” said Clyde, “do you mean the studies that were the most scientifically sound, well
grounded in evidence, and methodologically correct?” He took a breath. “Or do you mean those
studies that were widely and favorably received, whose recommendations were adopted, and that
made a real difference to health?”
“Of course,” I responded, “I meant both.”
A few days later, Clyde shared with me two lists, one for each meaning of “best”. I am pleased to
report that there was some overlap, but certainly not all, and I took from that a key lesson. The reason
it is important to do scientifically and analytically excellent work is not that this guarantees that a
study will have an effect. Rather, the reason is that in case a study does result in deeper understanding, new policy, and altered practice, you want the study to have pointed in the right direction.
I also learned that even important and accurate studies are seldom self-effecting to produce
change for the better in policy, practice, or health. One has to focus expressly, and as much, on
making a study known, understood, absorbed, and acted upon as on making it technically excellent. Through discussions with the IOM Council and others, we came to think of this as requiring
a combination of strategic communication, a willingness to create new partnerships and try novel
modes of outreach, and a constant focus on making a positive difference in the world. We adopted
“increasing the impact of what we do” as an overarching objective.
Although we have made progress in documenting, measuring, and increasing our impact
over the past decade, there is much more to be accomplished. One of the key inhibitors of greater
impact is a lack of flexible resources to apply to the communication, adoption, and implementation phases of our work. With some notable exceptions, sponsors typically consider the physical
(or electronic) report as their final product, but we have learned that we instead need to think of a
positive effect on policy, practice, and health as our final product. For this reason, the IOM Council
is planning a concerted effort to secure new, dedicated resources to enhance the impact of what we
do. You will be hearing much more about this in the months ahead, and, when the time comes, I
hope you will be as generous as you can to make this targeted fundraising effort a huge success.
Since our last IOM Annual Meeting, we enjoyed good fellowship and intellectual stimulation at three regional gatherings of IOM members and guests. Larry Jameson of the University of
Pennsylvania hosted a regional meeting last November in Philadelphia that focused on Alzheimer’s
disease. In March, we gathered at the Sanford Consortium in La Jolla, led by Ed Holmes, for a fascinating session on advances in stem cell medicine, and Bill Brody graciously hosted us for dinner
at the Salk Institute. Also in March, Jeff Balser, Bill Stead, and Ellen Wright Clayton of Vanderbilt
LETTER FROM THE PRESIDENT
3
organized a marvelous program in Nashville on the potential and pitfalls of gene and omics-based
treatment for cancer. We are looking forward to the next regional meeting in December at the
University of Washington in Seattle, where Paul Ramsey will host a session on the global burden of
disease and its implications for the United States.
The variety of topics covered in these regional meetings is suggestive of the scope of work
undertaken by the IOM. This past year was an exceptionally productive one, with more than 70
IOM reports and workshop summaries released over the past 12 months. Some studies, such as
the report on chimpanzees in biomedical and behavioral research, had virtually immediate impact
on policy. In other instances, we observed a direct connection between earlier reports, such as our
studies on access to dental care, and new legislative proposals, in this case for dental reform.
Our study and workshop topics included a number of foundational efforts that promise to
have a lasting influence. These included studies of under-appreciated disease problems, such as
epilepsy; risk factors, such as food safety and obesity; posttraumatic stress disorder and environmental exposures in theaters of war that threaten the health of our veterans; principles to guide
omics-based research that may lead to clinical interventions; public–private partnerships to
advance public health and promote healthy nutrition; priorities for vaccine development; methods
of monitoring HIV care in the United States.; strategies to assess the safety of approved drugs and
the safety of medication for children; and the integration of primary care and public health.
A number of other foundational studies in health care and policy gained special salience in
a year when the Supreme Court reaffirmed the essence of the Affordable Care Act. These reports
covered geographic adjustment in Medicare payments, adequacy of the workforce to meet mental
health needs of older adults, and an examination of how our nation can obtain the best care at
lower cost.
New partnerships and modes of outreach bore fruit over the past year. This spring marked
the broadcast of the Emmy-nominated HBO documentary series The Weight of the Nation. Produced as a partnership between HBO and the IOM, and enlisting the expertise of the National
Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and numerous
university faculty, this project aimed to reverse the rise in obesity in America. Kaiser Permanente
and the Michael & Susan Dell Foundation generously supported this project, which continues with
outreach to schools and communities. New infographics that convey key messages from reports,
such as accelerating progress in obesity prevention and achieving the best care at lower cost,
proved to be a very popular innovation this year. We increased reliance on social media, such as
Facebook and Twitter, to more actively engage our audiences. The Kellogg Fund enabled us to take
on new community programs based on IOM reports to promote healthy food choices and appropriate weight gain during pregnancy. And in June, the third annual Health Datapalooza conference, a
partnership among IOM, the Department of Health and Human Services (HHS), and many others,
attracted more than 1,400 attendees, more than double the previous year.
A number of IOM studies, activities, and other examples of our reach and effect are described
below. As you will see, the IOM demonstrated its worth in numerous ways over the past year. At
the end of this letter, you will find a visual representation of the “Degrees of Impact” of our work,
a gauge we find helpful in assessing the difference we are making, as well as an organization chart
and complete listing of IOM reports and workshop summaries from the past 12 months. This supplement also describes briefly the striking array of activities and new initiatives of IOM boards, a
summary of financial information, a listing of sponsors and donors whose support we gratefully
4
PRESIDENT’S REPORT SUPPLEMENT
acknowledge, and a roster of members who died this past year, yet whose example, achievements,
friendship, guidance, and lasting distinctions remain very much alive with us.
Making immediate impact
• Following the release of Accelerating Progress in Obesity Prevention: Solving
the Weight of the Nation, the Hawaii State Department of Health (DOH) and
the University of Hawaii issued a joint statement of support for the report. The
director of the DOH referred to the IOM report as “an invaluable resource”
for Hawaii’s new Childhood Obesity Prevention Task Force. In June 2012,
the DOH organized a symposium to review the IOM’s recommendations and
their evidence base.
• A special supplement published by the American Journal of Preventive
Medicine and the American Journal of Public Health was released in June
2012 to complement Primary Care and Public Health: Exploring Integration to
Improve Population Health. The articles included in the supplement identified the intersections between primary care and public health and the next steps for realizing integration.
• The Food and Drug Administration (FDA) issued draft guidance related to evaluating and
marketing modified risk tobacco products (MRTPs) in March 2012. The guidance drew on
the IOM report Scientific Standards for Studies on Modified Risk Tobacco Products, which
recommended what scientific evidence the FDA should require from companies sponsoring
MRTPs. The FDA is considering public comments received, the IOM report, and feedback
from a public FDA workshop before issuing its final guidance.
• Walmart rolled out a new icon in February 2012 to help its customers identify healthier foods.
The “Great for You” symbol will appear on packaging for foods that meet nutritional criteria
established by the 2010 Dietary Guidelines for Americans, the FDA, the U.S. Department of
Agriculture, and the IOM, beginning with Walmart’s Great Value–brand foods, Marketside
items, fruits, and vegetables. Andrea Thomas, Walmart’s Senior Vice President of Sustainability, said the chain made sure its effort was aligned with the IOM’s report on Front-of-Package
Nutrition Rating Systems and Symbols: Promoting Healthier Choices, which recommended a
simple, standard front-of-package system to help consumers make healthier choices more
easily. The IOM’s 2002 report on dietary reference intakes is cited as the basis for the limit on
added sugars.
• The National Human Genome Research Institute (NHGRI) credited the work of the IOM
Roundtable on Translating Genomic-Based Research for Health and cited the workshop
summary Integrating Large-Scale Genomic Information into Clinical Practice for identifying
the need for a database of genetic variants with annotated information about potential clinical impact. NHGRI has presented a concept clearance to their advisory council to support a
request for application to develop such a database.
• Duke University released a statement in support of Evolution of Translational Omics: Lessons
Learned and the Path Forward. They pledged to incorporate the IOM’s recommendations into
their “ongoing efforts to strengthen the rigor of [Duke’s] research enterprise.”
LETTER FROM THE PRESIDENT
5
• In May 2012, HHS Secretary Kathleen Sebelius directed HHS operating
divisions to develop metrics for charting the progress of the National
HIV/AIDS Strategy that are consistent with the core indicator domains
recommended in Monitoring HIV Care in the United States: Indicators
and Data Systems. On July 24, 2012, Secretary Sebelius approved a set
of seven common core indicators for monitoring HHS-funded HIV services aligned with the IOM recommendations as well as with indicators
from the National Quality Forum and the National Committee for Quality Assurance.
• Beginning July 1, 2012, authors submitting manuscripts for publication
in Endocrinology are now required to specify the sex of experimental animals in both the title
and the methods section of the paper. Authors must also specify the sex of the animal from
which any primary cells or cultures were derived; reporting the sex of cell lines will be encouraged but not required. As part of the justification for the new policy, editor Jeffrey Blaustein
referenced the discussions at the 2011 IOM workshop Sex-Specific Reporting of Scientific
Research whose summary by the same title was issued in 2012. Dr. Blaustein presented at the
workshop on the implications of sex-specific reporting policies for journals.
• On the day of the release of Chimpanzees in Biomedical and Behavioral Research: Assessing
the Necessity, NIH Director Francis Collins announced that the agency would not issue “any
new awards for research involving chimpanzees until processes for implementing the [IOM]
recommendations are in place” (December 15, 2011). Dr. Collins also indicated his full support
for the IOM report and that he would convene “a working group within the NIH Council of
Councils to provide advice on the implementation of the recommendations.”
• Chimpanzees in Biomedical and Behavioral Research: Assessing the Necessity also has the potential to guide research in the private sector. For example, the New Iberia Research Center Chimpanzee Advisory Committee, which conducts chimpanzee research supported by industry at
the University of Louisiana at Lafayette, drafted a policy with de-selection criteria for chimpanzees that reflects the de-selection criteria and recommendations from the IOM’s report.
• After the release of Safe and Effective Medicines for Children: Pediatric Studies Conducted Under BPCA and PREA, the Best Pharmaceuticals for Children
Act (BPCA) and the Pediatric Research Equity Act (PREA) were permanently
reauthorized under the FDA Safety and Innovation Act of 2012. Several of the
law’s provisions are consistent with the IOM’s recommendations, in particular the new requirement for the FDA’s Pediatric Review Committee and the
Office of Pediatric Therapeutics to include expertise in neonatology. In addition, the FDA is to report on progress made on the recommendations in the
IOM report by 2016.
• The PSO Services Group, one of the Agency for Healthcare Research and
Quality’s (AHRQ) listed National Patient Safety Organizations, has established
a multidisciplinary National Medical Safety Board (NMSB) to conduct safety investigations.
The group’s action is based on a recommendation from Health IT and Patient Safety: Building Safer Systems for Better Care. When invited by health care providers, the NMSB will put
6
PRESIDENT’S REPORT SUPPLEMENT
together “Go-Teams” to conduct independent, on-site, nonpunitive safety investigations. Any
findings and recommendations will be submitted to the providers under the protection of the
Patient Safety and Quality Improvement Act of 2005.
Speaking on topics of national importance
Many reports issued this year deserve the attention of policy makers, practitioners, researchers,
industry, and the public. Among these:
•Best Care at Lower Cost: The Path to Continuously Learning Health Care in America noted
that emerging tools like computing power, connectivity, team-based care, and systems engineering can support the transition to a continuously learning health system
• Ranking Vaccines: A Prioritization Framework – Phase I: Demonstration of Concept and a Software Blueprint described a decision-support model and the blueprint of software called the
Strategic Multi-Attribute Ranking Tool for Vaccines, or SMART Vaccines, that should help
decision makers prioritize new vaccines.
• Geographic Adjustment in Medicare Payment: Phase II—Implications for Access, Quality, and
Efficiency evaluated how suggested changes to the Medicare payment system would affect
hospitals and clinical practitioners. The Centers for Medicare and Medicaid Services (CMS)
has already adjusted some payment to providers in line with the IOM’s first report in the
series, Geographic Adjustment in Medicare Payment: Phase I—Improving Accuracy. CMS is
continuing to evaluate all of the IOM’s recommendations.
• The Mental Health and Substance Use Workforce for Older Adults: In Whose Hands? examined
the type of care patients in the United States are currently receiving, and how to improve it.
• Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad, along
with For the Public’s Health: Investing in a Healthier Future; Living Well with Chronic Illness:
A Call for Public Health Action; Breast Cancer and the Environment: A Life Course Approach;
and Crisis Standards of Care: A Systems Framework for Catastrophic Disaster Response presented measures to improve and protect public health.
• Ethical and Scientific Issues in Studying the Safety of Approved Drugs recommended implementing a life cycle approach to drug safety oversight that could allow the FDA to better
anticipate post-approval research needs and improve drug safety for all Americans.
• IOM guidance for federal agency research included A Review of NASA’s Human Research
Program’s Scientific Merit Assessment Process—Letter Report.
• Reports on military health included this year’s Long-Term Health Consequences of Exposure to
Burn Pits in Iraq and Afghanistan; Treatment for Posttraumatic Stress Disorder in Military and
Veteran Populations: Initial Assessment; and 2011’s Cognitive Rehabilitation Therapy for Traumatic Brain Injury: Evaluating the Evidence. In these and other reports, the IOM extends its
decades-long record of attending to the health needs of our active-duty military and veterans.
• Following the release of the IOM report Epilepsy Across the Spectrum: Promoting Health
and Understanding, a number of organizations released statements in support of the report,
including five epilepsy health care provider groups, the American Academy of Neurology,
Vision 20/20, and the Epilepsy Foundation.
LETTER FROM THE PRESIDENT
7
Shaping health policy
The impact of some IOM reports on contemporary policy debate is often felt many years after their
initial publication. Below is a brief summary of several instances where past reports were particularly influential this year:
Government agencies
• Three NIH program announcements were released in February 2012 for research on the
health of LGBTI (lesbian, gay, bisexual, transgender, and intersex) populations. The background information for each announcement cites The Health of LGBT People: Building a
Foundation for Better Understanding and the IOM committee’s finding that the evidence
related to the health of these populations is thin.
• In August 2012, the Department of Veterans Affairs (VA) proposed substituting early-onset
peripheral neuropathy for acute and subacute neuropathy on its list of diseases presumed to be
connected to service-related Agent Orange exposure. The change would eliminate the requirement for compensation that symptoms must have resolved themselves 2 years after they initially appeared. The VA is receiving public comments on the proposal through October 2012.
Veterans and Agent Orange: Update 2010 found “limited or suggestive evidence of association”
between Agent Orange exposure and persistent, early-onset peripheral neuropathy.
• Sparked by the release of three 2006 IOM reports—Emergency Care for Children: Growing
Pains; Hospital-Based Emergency Care: At the Breaking Point; and Emergency Medical Services at the Crossroads—the NIH began an effort to examine its research activities in emergency medicine and to hear from investigators and stakeholders in the field. The IOM reports
found the emergency medical system to be overburdened, underfunded, and highly fragmented. The NIH effort led to the creation in 2012 of the Office of Emergency Care Research
(OECR), a division within the NIH’s National Institute of General Medical Sciences. OECR
coordinates and fosters research across the NIH related to the emergency care setting.
• The National Prevention Council released a national prevention strategy report in which
“Mental and Emotional Well-Being” is included as a priority area, with Preventing Mental, Emotional, and Behavioral Disorders Among Young People listed as one of the two key
resources for that section, the other being the Surgeon General’s mental health report.
Congress
• The Senate HELP Subcommittee on Primary Health and Aging held a hearing on the dental
crisis in the United States on February 29, 2012. IOM committee member Shelly Gehshan
participated in the hearing and described the findings and recommendations from Advancing Oral Health in America and Improving Access to Oral Health Care for Vulnerable and
Underserved Populations. Senator Bernard Sanders, chairman of the subcommittee, released
a report in conjunction with the hearing that cited both IOM reports.
• Senator Bernard Sanders introduced the Comprehensive Dental Reform Act of 2012 on
June 7, 2012. The bill would expand access to dental care and is directly aligned with recommendations from the IOM reports Improving Access to Oral Health Care for Vulnerable and
Underserved Populations and Advancing Oral Health in America. Both IOM reports are cited
in the bill’s findings section.
8
PRESIDENT’S REPORT SUPPLEMENT
Professional societies and the professions
• The American Cancer Society (ACS) revised its methods for developing and communicating
cancer screening guidelines according to the IOM’s recommendations in both Clinical Practice Guidelines We Can Trust and Finding What Works in Health Care. In 2010, an ACS workgroup was convened to evaluate the process for developing cancer screening guidelines, and
“after the IOM reports were released in March 2011, the workgroup refined its recommendations so the ACS process would be consistent with the latest standards for clinical practice
guideline development,” states a December 14, 2011, JAMA article. The article includes a
side-by-side comparison of the IOM’s recommendations and the new ACS process, which
aligns with IOM principles by “creating a single generalist group for writing the guidelines,
commissioning independent systematic evidence reviews, and clearly articulating the benefits, limitations, and harms associated with a screening test.”
• The American Academy of Pediatrics (AAP) endorsed Dietary Reference Intakes for Calcium
and Vitamin D and retired its two existing statements related to calcium and vitamin D and
infants, children, and adolescents (from 2006 and 2008). The AAP’s endorsement of the IOM
report will apply for 5 years unless retired or revised by the IOM before then.
• The Robert Wood Johnson Foundation’s “Future of Nursing: Campaign for Action” has continued to make strides in implementing the recommendations from The Future of Nursing:
Leading Change, Advancing Health. Action coalitions—groups of nurses and other health care
providers, employers, patients, and others—have been formed in 49 states. Most coalitions
have focused on, and already made progress toward, the IOM’s recommendation that 80 percent of the nursing workforce have a BSN degree by 2020.
Global models
• The Peace Corps announced a new Global Health Service Partnership (GHSP) on March 13,
2012, which will deploy physicians and nurses to serve as medical and nursing faculty members in developing countries. The new faculty members are meant to help developing countries
overcome shortages of health care professionals by adding capacity and support. GHSP, funded
through the President’s Emergency Plan for AIDS Relief (PEPFAR), is expected to begin in
2013, placing approximately 30 faculty members in Tanzania, Malawi, and Uganda. A similar
concept for a global health service corps was recommended in the 2005 IOM report Healers
Abroad: Americans Responding to the Human Resource Crisis in HIV/AIDS and has been advocated by many others. Vanessa Kerry, who has become executive director of the new Global
Health Service Corps, which will assist the Peace Corps with program administration, worked
to develop the program with Fitzhugh Mullan, who chaired the IOM report committee.
• Participants from an international workshop of the Forum on Drug Discovery, Development,
and Translation on drug-resistant tuberculosis (TB) were inspired to develop a new virtual
community called “The Sentinel Project on Pediatric Drug-Resistant Tuberculosis.” The network is a project of Dr. Mercedes Becerra, Harvard Medical School, and Dr. Soumya Swaminathan, National Institute for Research in Tuberculosis in Chennai, India, who were introduced to each other when they co-chaired a session on pediatric drug-resistant TB at the
forum’s workshop in New Delhi, India, in April 2011. The aim of the network is to develop
and deploy evidence-based strategies to prevent child deaths from drug-resistant TB by con-
LETTER FROM THE PRESIDENT
9
vening a research and learning community that will generate and disseminate knowledge
and data for immediate action. As of early November 2011, more than 40 individuals from 15
countries had already joined the network.
Reaching out more effectively
The IOM continues to extend its reach using social media. Since last year, our Twitter followers
have grown four-fold to more than 8,000 followers, and after launching the IOM’s Facebook page
at last year’s annual meeting, we have more than 3,000 “likes”. More importantly, we are interacting with both influencers and the public in a two-way conversation, which we rarely are able to do
outside meetings and workshops. We have been key players in the online conversation taking place
alongside the “real” conversation during popular events such as the Health Datapalooza, the IOM
Workshop on the Health Impact Assessment of New Energy Sources: Shale Gas Extraction, and the
airing of the Weight of the Nation series.
Social media is just one of the new media the IOM has further embraced this past year. As we
work to reach a broader audience, we are increasing our use of data visualization to augment public understanding of both the evidence base and the findings of our reports. An IOM infographic
explains visually, for example, the five essential areas that need improvement if the nation is to
accelerate obesity prevention, as laid out in the IOM report Accelerating Progress in Obesity Prevention: Solving the Weight of the Nation (available at www.iom.edu/obesitygraphic). That infographic was published as a poster in both English and Spanish and are available for purchase. More
than 5,000 copies have been distributed. This summer, the IOM released Geographic Adjustment in
Medicare Payment: Phase II—Implications for Access, Quality, and Efficiency, a follow-up to a 2011
report. The report provides multitudes of data, but the data are available only as a spreadsheet,
requiring complicated searches to access specific data points. But this fall, we will provide a new
reporting function to allow users to run their own reports to see how the IOM’s recommendations
would change Medicare payment in various geographic areas. And to extend the reach of the IOM
report Primary Care and Public Health: Exploring Integration to Improve Population Health, we
developed a slide set and video that offer a case study to make more clear how the integration of
these areas can improve health. The video (available at www.iom.edu/primarycarepublichealthvideo) is on YouTube as well as the IOM website, and the slides can be downloaded and presented
at meetings or other venues. These new tools are important and valuable, and we continue to seek
opportunities to develop them.
Finally, 2012 has been a breakthrough year for the IOM’s Kellogg Health of the Public Fund.
Endowed by the W.K. Kellogg Foundation in 2003, the Kellogg Fund was designed to spread our
messages to the public and community leaders, particularly in vulnerable or disadvantaged communities. We use the funds to develop innovative communications activities that can better reach
these audiences. This year, we have embarked on two large-scale projects: the expansion of the
IOM’s Smart Bites program, which is a community-based program designed to provide youth and
families with nutrition information to help them make informed, healthy decisions when dining
out, and a campaign to reach Latina women with pregnancy weight gain recommendations. The
Smart Bites program was piloted in Bowling Green, Kentucky, in 2009-2010, and this year we are
expanding it to three new communities. The first—Howard County, Maryland—has been selected,
and we continue to search for two others to begin in 2013. In addition, we have launched the IOM’s
10
PRESIDENT’S REPORT SUPPLEMENT
first public health campaign aimed at Latina women. We have developed exciting new partnerships and materials to help spread the IOM’s pregnancy weight guidelines from the 2009 report
Weight Gain During Pregnancy: Reexamining the Guidelines to Mexican American women, a population at high risk for obesity and complications during pregnancy. The interest among partners
has been high, and we hope that targeting a specific audience will help us have a greater impact. In
addition to these activities, we will identify new Kellogg Fund projects for 2013.
The IOM has a new product for the public—its “Perspectives.” These articles offer observations
and opinions of leading experts on a variety of innovations and challenges in health and health care.
Designed to expand knowledge about health, IOM Perspectives comprise two forms—discussion
papers and commentaries. In either format, these publications provide outside experts the opportunity to reflect on current challenges in the health system and to foster insightful discussion, and they
are a new means of furthering the IOM’s mission. Some have already had an impact. For example,
the strategies for improving quality and reducing costs outlined in “A CEO Checklist for High-Value
Care,” an IOM discussion paper authored by CEOs from 11 health care institutions, were picked up
and referenced by several news outlets following the paper’s release in June 2012. The American College of Physician Executives announced support for the checklist in a June press release.
Supporting new fellows
Once again, we have had the privilege of enlarging our Anniversary Fellows Program this year.
Since the initiation of the program in 2005, nine fellowships have been awarded. The latest fellowship to be added is sponsored by the American College of Clinical Pharmacy and the American
Association of Colleges of Pharmacy, and this new fellow will join us in October. We also launched
the new FDA Tobacco Regulatory Science Fellowship, which is designed for mid-career professionals to gain experience and expertise to further define and develop the field of regulatory science as it relates to the regulation of tobacco products and the FDA’s new authorities under the
Family Smoking Prevention and Tobacco Control Act.
The IOM could not function without its talented and dedicated staff, and every facet of our
work depends on the generosity and active participation of our donors, members, and other volunteers. It is gratifying to note that member financial support increased last year, and you willingly
stepped forward to serve on our commmittees, review panels, workshops, forums, and roundtables
time and time again. From the bottom of my heart, I thank you for your service. Truly, the success
and impact of the IOM depend utterly on you.
Sincerely,
Harvey V. Fineberg, M.D., Ph.D.
11
DEGREES OF IMPACT
Institute of Medicine
Degrees of Impact
Effecting
Change
Inspiring
Action
Informing the
Field
Receiving
Recognition
Spreading the
Message
Improved Health Outcomes
Legislation Enacted
Designation of Funding/Appropriations
Policy Change, Including Organizational Policy
Development/Revision of Guidelines
Legislation Introduced
Development of Action Group/Task Force
Advocacy Initiatives
Research Initiative Implemented
Basis of RFA/RFP
Educational Efforts
Subject of a Professional Meeting
Subject of a Congressional Hearing/Investigation
Formal Response (Agency, Sponsor, Stakeholder)
Awards
Noteworthy Media Coverage
Published Article in Journal
12
PRESIDENT’S REPORT SUPPLEMENT
Institute of Medicine
Organizational Chart
President
Harvey V. Fineberg
Home Secretary
Stephen J. Ryan
Foreign Secretary
Jo Ivey Boufford
Executive Office
The Leonard D. Schaeffer
Executive Officer
Judith A. Salerno
Office of Finance and
Administration
Janet A. Stoll
Director
Deputy Executive Officer
Clyde J. Behney
Office of Council and
Membership Services
Judith Shamir
Director
Office of
Development
Clare Flanagan
Director of
Development
Office of
Communications
Lauren Tobias
Director of
Communications
Boards
Population Health and
Public Health Practice
Rose Marie Martinez
Director
Health Sciences Policy
Health Care Services
Andrew M. Pope
Director
Roger C. Herdman
Director
Global Health
Food and Nutrition
Patrick W. Kelley
Director
Linda D. Meyers
Director
Children, Youth,
and Families
Kimber Bogard
Director
African Science
Academy Development
Patrick W. Kelley
Director
Health of Select Populations
Rick Erdtmann
Director
Health Policy Educational
Programs and Fellowships
Marie Michnich
Director
Roundtables, Forums, and Other Select Activities
Food Forum
Forum on Aging, Disability, and
Independence
Forum on Drug Discovery,
Development, and Translation
Forum on Neuroscience and
Nervous System Disorders
Roundtable on Environmental Health
Sciences, Research, and Medicine
Global Forum on Innovation in Health
Professional Education
Roundtable on the Promotion of Health
Equity and the Elimination of Health
Disparities
Health Data Initiative
Forum on Global Violence Prevention
Health Literacy Roundtable
Forum on Medical and Public Health
Preparedness for Catastrophic Events
Medical Follow-Up Agency
Forum on Microbial Threats
National Cancer Policy Forum
Roundtable on Translating GenomicBased Research for Health
Roundtable on Value & Science-Driven
Health Care
PRESIDENT’S OFFICE AND EXECUTIVE OFFICE STAFF
Institute of Medicine
Office of the President
Harvey V. Fineberg, President
Sherla Allen, Executive Assistant
Morgan Heller, Assistant to the President for Special Projects
Executive Office
Judith A. Salerno, Leonard D. Schaeffer Executive Officer
Jody Evans, Executive Assistant
Clyde J. Behney, Deputy Executive Officer
Sarah Ziegenhorn, Senior Program Assistant
Office of the Home Secretary
Stephen J. Ryan
Office of the Foreign Secretary
Jo Ivey Boufford
Office of Council and Membership Services
Judith Shamir, Director
Donna D. Duncan, Deputy Director
Office of Reports and Communications
Lauren Tobias, Director
Abbey Meltzer, Deputy Director
Office of Finance and Administration
Janet A. Stoll, Director
Gary Walker, Deputy Director
Office of Development
Clare Flanagan, Director
13
RECENT PUBLICATIONS
15
Recent Publications
Digital Data Improvement Priorities for Continuous Learning in Health and Health Care – Workshop
Summary (September 28, 2012)
Fitness Measures and Health Outcomes in Youth (September 27, 2012)
Substance Use Disorders in the U.S. Armed Forces (September 17, 2012)
How Far Have We Come in Reducing Health Disparities – Workshop Summary (September 12,
2012)
Improving Food Safety Through a One Health Approach – Workshop Summary (September 10,
2012)
From Neurons to Neighborhoods: An Update – Workshop Summary (September 7, 2012)
Best Care at Lower Cost: The Path to Continuously Learning Health Care in America (September 6,
2012)
Genome-Based Therapeutics: Targeted Drug Discovery and Development – Workshop Summary
(September 5, 2012)
Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures
Acceleration Network – Workshop Summary (August 22, 2012)
Post-Incident Recovery Considerations of the Health Care Service Delivery Infrastructure –
Workshop Summary (July 31, 2012)
A Review of NASA’s Human Research Program’s Scientific Merit Assessment Processes – Letter
Report (July 26, 2012)
How Can Health Care Organizations Become More Health Literate? – Workshop Summary (July 18,
2012)
Geographic Adjustment in Medicare Payment: Phase II – Implications for Access, Quality, and
Efficiency (July 17, 2012)
Informatics Needs and Challenges in Cancer Research – Workshop Summary (July 16, 2012)
Treatment for Posttraumatic Stress Disorder in Military and Veteran Populations: Initial Assessment
(July 13, 2012)
The Mental Health and Substance Use Workforce for Older Adults: In Whose Hands? (July 10,
2012)
16
PRESIDENT’S REPORT SUPPLEMENT
Research Methods to Assess Dietary Intake and Program Participation in Child Day Care: Application
to the Child and Adult Care Food Program – Workshop Summary (June 25, 2012)
Communications and Technology for Violence Prevention – Workshop Summary (June 13, 2012)
Building Public–Private Partnerships in Food and Nutrition – Workshop Summary (June 5, 2012)
International Animal Research Regulations: Impact on Neuroscience Research – Workshop Summary
(May 29, 2012)
Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza
Pandemic – Workshop Series Summary (May 17, 2012)
Alliances for Obesity Prevention: Finding Common Ground – Workshop Summary (May 11, 2012)
Ranking Vaccines: A Prioritization Framework – Phase I: Demonstration of Concept and a Software
Blueprint (May 10, 2012)
Accelerating Progress in Obesity Prevention: Solving the Weight of the Nation (May 8, 2012)
Ethical and Scientific Issues in Studying the Safety of Approved Drugs (May 1, 2012)
Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions –
Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and
the Indian Council of Medical Research (April 27, 2012)
Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for
2020 – Workshop Summary (April 13, 2012)
For the Public’s Health: Investing in a Healthier Future (April 10, 2012)
Building a Resilient Workforce: Opportunities for the Department of Homeland Security – Workshop
Summary (April 9, 2012)
Child Maltreatment Research, Policy, and Practice for the Next Decade – Workshop Summary (April
5, 2012)
Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad (April 4,
2012)
The Role of Obesity in Cancer Survival and Recurrence – Workshop Summary (April 3, 2012)
Country-Level Decision Making for Control of Chronic Diseases – Workshop Summary (April 2,
2012)
RECENT PUBLICATIONS
17
Epilepsy Across the Spectrum: Promoting Health and Understanding (March 30, 2012)
Primary Care and Public Health: Exploring Integration to Improve Population Health (March 28,
2012)
Evolution of Translational Omics: Lessons Learned and the Path Forward (March 23, 2012)
Crisis Standards of Care: A Systems Framework for Catastrophic Disaster Response (March 21,
2012)
Genome-Based Diagnostics: Clarifying Pathways to Clinical Use – Workshop Summary (March 20,
2012)
Nutrition and Healthy Aging in the Community – Workshop Summary (March 20, 2012)
Monitoring HIV Care in the United States: Indicators and Data Systems (March 15, 2012)
Safe and Effective Medicines for Children: Pediatric Studies Conducted Under BPCA and PREA
(February 29, 2012)
Measuring Progress in Obesity Prevention – Workshop Report (February 23, 2012)
Alzheimer’s Diagnostic Guideline Validation: Exploration of Next Steps – Workshop Summary (February 16, 2012)
Facilitating State Health Exchange Communication Through the Use of Health Literate Practices –
Workshop Summary (February 14, 2012)
Living Well with Chronic Illness: A Call for Public Health Action (January 31, 2012)
Barriers to Integrating Crisis Standards of Care Principles into International Disaster Response
Plans – Workshop Summary (January 23, 2012)
Sex-Specific Reporting of Scientific Research – Workshop Summary (January 13, 2012)
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development –
Workshop Summary (December 21, 2011)
Chimpanzees in Biomedical and Behavioral Research: Assessing the Necessity (December 15, 2011)
Scientific Standards for Studies on Modified Risk Tobacco Products (December 14, 2011)
Allied Health Workforce and Services – Workshop Summary (December 8, 2011)
18
PRESIDENT’S REPORT SUPPLEMENT
Breast Cancer and the Environment: A Life Course Approach (December 7, 2011)
Information Sharing and Collaboration: Applications to Integrated Biosurveillance – Workshop
Summary (November 30, 2011)
The Science and Applications of Synthetic and Systems Biology – Workshop Summary (November 23,
2011)
The Early Childhood Care and Education Workforce: Challenges and Opportunities – A Workshop
Report (November 15, 2011)
Improving Health Literacy Within a State – Workshop Summary (November 14, 2011)
Integrating Large-Scale Genomic Information into Clinical Practice – Workshop Summary (November 11, 2011)
Health IT and Patient Safety: Building Safer Systems for Better Care (November 8, 2011)
Promoting Health Literacy to Encourage Prevention and Wellness – Workshop Summary (November
1, 2011)
Long-Term Health Consequences of Exposure to Burn Pits in Iraq and Afghanistan (October 31,
2011)
Facilitating Collaborations to Develop Combination Investigational Cancer Therapies – Workshop
Summary (October 31, 2011)
Social and Economic Costs of Violence – Workshop Summary (October 25, 2011)
Front-of-Package Nutrition Rating Systems and Symbols: Promoting Healthier Choices (October 20,
2011)
Public Engagement and Clinical Trials: New Models and Disruptive Technologies – Workshop
Summary (October 14, 2011)
Cognitive Rehabilitation Therapy for Traumatic Brain Injury: Evaluating the Evidence (October 11,
2011)
Essential Health Benefits: Balancing Coverage and Cost (October 6, 2011)
The Richard and Hinda Rosenthal Lecture 2011: New Frontiers in Patient Safety (October 5, 2011)
Patients Charting the Course: Citizen Engagement in the Learning Health System – Workshop
Summary (October 3, 2011)
PROGRAM LISTING
19
Board on African Science Academy Development Initiative
Patrick W. Kelley, M.D., Director
Organized: 2004
The principal goal of the African Science Academy Development Initiative (ASADI) is to advance
the ability of nations in Africa to address their most serious health challenges by (1) enhancing the
capacity of African academies of science to provide independent, evidence-based policy advice to
their governments, and (2) building African governments’ appreciation of and demand for advice
from these academies.
This 10-year effort engages nationally-based science academies in Cameroon, Ghana, Kenya,
Nigeria, Senegal, South Africa, Uganda, and, most recently, Ethiopia. The African regional science
academy, the African Academy of Sciences (AAS), and the Network of African Science Academies
(NASAC) are also engaged.
The specific objectives of this initiative include the following:
• Select African academies of science with the greatest promise to provide evidence-based
health policy advice;
• Provide training for staff members from each participating academy to prepare them to support the conduct of policy advisory activities and manage finances;
• Promote continuous discussion and debate of evidence-based policy development in crosscutting areas of health and sustainable development;
• Strengthen academy policy advisory capacity through mentored policy advisory activities;
• Strengthen substantive, managerial, and fiscal independence of academies of science through
support of independent policy advisory activities and financially matched activities;
• Develop human, material, and organizational infrastructure in each academy to support the
contribution of science to policy advisory work in the future;
• Build a regional alliance through annual symposia and learning collaboratives to enable participating academies and leading scientists in non-participating countries to learn from and
support each other as they develop their roles;
• Develop demand from African governments and civil society organizations for evidencebased policy advice from African academies of science; and
• Externally evaluate project outcomes and the effectiveness of the processes used to achieve
project outcomes.
20
PRESIDENT’S REPORT SUPPLEMENT
Recent Activities
Cameroon Academy of Sciences (CAS)
The Cameroon Academy of Sciences undertook a consensus study on onchocheriasis control and
a dissemination activity on the IOM report: Promoting Cardiovascular Health in the Developing
World: A Critical Challenge to Achieve Global Health during this reporting period. CAS currently
receives a subvention from their government and also participates in monthly mentoring sessions
via Skype with ASADI staff.
Ethiopian Academy of Sciences (EAS)
The Ethiopian Academy of Sciences convened three convening activities during the reporting
period:
• A science congress organized under the theme Science and Technology – Survival of a
Nation
• Workshop on Engineering and Technology in Ethiopia: Challenges and Prospects
• National workshop on the Status of Agricultural Science & Technology in Ethiopia
With the ASADI grant, the EAS’ staff strength has grown from one person to six with the recent
hire of an Executive Director. Also, the EAS recently moved into an office building donated by the
Ethiopian government and is currently working with the government to institute a government
subvention. Furthermore, monthly mentoring sessions were conducted via video conference technology.
Nigerian Academy of Science (NAS)
The Nigerian Academy of Science held two workshops in execution of its PREVIEW project.
PREVIEW is a contract with the Nigerian Ministry of Health to “focus on the use of evidence-based
research and other information in health policy making” and has the ultimate goal of strengthening health care systems in Nigeria. This activity was funded by the World Health Organization.
Furthermore, the NAS published a report in coordination with the 2012 ASADI Annual
Meeting on the topic of climate change in Africa.
As hosts of the 2012 ASADI Annual Meeting, the NAS conducted three planning meetings,
including a 3-day international retreat held at the Rockefeller Foundation Bellagio Center in Italy
in February 2012 to shape the meeting agenda.
Uganda National Academy of Science (UNAS)
UNAS undertook the following policy advisory activities:
• Establishment of a standing committee on malaria vaccines;
• Conduct of Workshop on A Long-Term Strategy for HIV/AIDS in Uganda: A Call to Action;
PROGRAM LISTING
21
• Dissemination activities for the nutritionalization of agriculture study published in 2010;
and
• Host for the 2011 ASADI Annual Meeting and release of the publication Informing Strategies,
Improving Results: The Role of Civil Society Organisations in Managing for Results in Africa’s
Health Sector
Academy of Science of South Africa (ASSAf)
As reported last year, South African participation in the ASADI program ended in 2011 after ASSAf
attained its developmental goal of self-sustainability. However, ASSAf continues to play a leadership role in helping to develop academies in the South Africa Development Community (SADC),
namely those in Namibia, Mozambique, Mauritius, and Zimbabwe.
2011 Annual Meeting
The seventh annual ASADI meeting, Aid Effectiveness in Africa’s Health Sector, was hosted by the
Uganda National Academy of Sciences on November, 13-16, 2011 in Kampala, Uganda. The conference illuminated the role of civil society organizations in addressing government and donor
concerns in aid and development effectiveness. The report Informing Strategies, Improving
Results: The Role of Civil Society Organisations in Managing for Results in Africa’s Health Sector
was launched.
2012 Annual Meeting
Planning is currently under way for Annual Meeting of the African Science Academies (AMASA, or
A8), formerly known as the Annual International Meeting of the African Science Academy Development Initiative (ASADI 8), as the African academies gradually embrace a more independent,
post-ASADI context. AMASA will be hosted by the Nigerian Academy of Sciences in Lagos on
November 11-14, 2012. The focus of this year’s meeting is climate change and its impact on health
and food security in Africa. As part of the preparations, a 3-day international retreat was held at the
Rockefeller Foundation Bellagio Center in Italy in February 2012. This groundbreaking initiative
of the African science academies explored a common vision and opportunities related to climate
change effects in Africa among international experts, donors, and vested stakeholders. The outcome of this retreat established the key themes of the upcoming annual meeting.
Board Roster
Enriqueta C. Bond (Chair), Marshall, VA
Jo Ivey Boufford (Ex Officio, Foreign Secretary, IOM), New York Academy of Medicine, New
York, NY
Michael Clegg (Ex Officio, Foreign Secretary, NAS), Department of Botany and Plant
Sciences, University of California, Riverside, CA
22
PRESIDENT’S REPORT SUPPLEMENT
Venkatesh Narayanamurti (Ex Officio, Foreign Secretary, NAE), Harvard School of Engineering and Applied Sciences, Boston, MA
Princeton Lyman, Council on Foreign Relations, Washington, DC
Narciso Matos, Foundation for Community Development, Maputo, Mozambique
Cheikh Mbacké, William and Flora Hewlett Foundation, Dakar, Senegal
Romain Murenzi, TWAS – The Academy of Sciences for the Developing World, Trieste,
Italy
Board on Children, Youth, and Families
Kimber Bogard, Ph.D., Director
Organized: 1993
The Board on Children, Youth, and Families (BCYF) is a non-governmental, scientific unit within
the National Academy of Sciences that convenes top experts from across multiple disciplines to
analyze the best available evidence on critical issues facing children, youth, and families today.
Our ability to evaluate research simultaneously from the perspectives of health, education, and
the social and behavioral sciences allows us to shed light on innovative and influential solutions
to inform the nation. Our range of methods—from rapidly convened workshops to consensus
reports—allows us to respond with the timeliness and depth required to make the largest possible
impact on the health and well-being of children, youth, and their families throughout the entire life
cycle. BCYF reports are independent analyses of the science that go through a rigorous external
peer review process. Therefore, our recommendations are trusted and implemented at every level,
from policy makers to practitioners.
Recent Reports
2012
• From Neurons to Neighborhoods: An Update – Workshop Summary
• Child Maltreatment Research, Policy, and Practice for the Next Decade – Workshop
Summary
• The Early Childhood Care and Education Workforce: Challenges and Opportunities – A
Workshop Report
2011
• Toward an Integrated Science of Research on Families – Workshop Report
• Child and Adolescent Health and Health Care Quality: Measuring What Matters
PROGRAM LISTING
23
• Advancing Oral Health in America (with Board on Health Care Services)
• Improving Access to Oral Health Care for Vulnerable and Underserved Populations
2010
• The Science of Adolescent Risk-Taking – Workshop Report
Current Activities/Studies in Progress
• IOM report on pregnancy weight gain guidelines: dissemination workshops and related
activities (with Food and Nutrition Board)
• Commercial Sexual Exploitation and Sex Trafficking of Minors in the United States
• Child Maltreatment Research, Policy, and Practice for the Next Generation: Phase Two
• Follow-up to the 1982 IOM study Research Issues in the Assessment of Birth Settings: A Workshop
• Investing in Young Children Globally: A Planning Meeting
• Strengthening the Workforce from the Early Years to the Early Grades: A Planning
Meeting
• Forum on Global Violence Prevention (with Board on Global Health)
• Outcome and Impact Evaluation of Global HIV/AIDS Programs Implemented Under the
Lantos-Hyde Act of 2008 (with Board on Global Health)
Projects in Development
• Sports-Related Concussions in Youth
• Improving the Health, Safety and Well-being of Young Adults, a Hidden Population: A
Workshop
• Fostering Early School Success for English Learners: Toward New Directions in Policy,
Practice, and Research
• Promoting Children’s Cognitive, Affective, and Behavioral Health Forum
• Consensus Standards for Benefit-Cost Analysis of Preventive Interventions for Children,
Youth, and Families
• Promoting Health and Chronic Illness Management for Adolescents Transitioning to
Adulthood
• Neurocognitive and Neurodevelopmental Effects of Complex Illness in Young Children
• A Developmental Approach to Childhood Obesity: The Fetal and Early Childhood Years
• Community Programs to Promote Youth Development: Moving the Agenda Forward
• Multi-Generational Families under One Roof: Health, Economics, and Overall Well-Being
• Promoting Positive School Contexts to Reduce Bullying Behaviors and Promote Learning
24
PRESIDENT’S REPORT SUPPLEMENT
Board Roster
Bernard Guyer (Chair), Bloomberg School of Public Health, The Johns Hopkins University,
Baltimore, MD
Shari Barkin, Department of Pediatrics, Vanderbilt University, Nashville, TN
Thomas F. Boat, Health Center, College of Medicine, University of Cincinnati, OH
David A. Brent, University of Pittsburgh School of Medicine, PA
B. J. Casey, Departments of Psychiatry, Neurology, and Neuroscience, Weill Medical College of
Cornell University, New York, NY
Debbie I. Chang, Nemours Health and Prevention Services, Newark, DE
Janet M. Currie, Woodrow Wilson School of Public and International Affairs, Princeton
University, NJ
Patrick H. DeLeon, Uniformed Services University of the Health Sciences, Bethesda, MD
Angela Diaz, Mount Sinai School of Medicine, New York, NY
Gary W. Evans, Department of Design & Environmental Analysis and Department of Human
Development, Cornell University, Ithaca, NY
Elena Fuentes-Afflick, University of California, San Francisco, and San Francisco General
Hospital, CA
Eugene E. Garcia, Mary Lou Fulton Teachers’ College, Arizona State University
J. David Hawkins, School of Social Work, University of Washington, Seattle
Nancy S. Landale, Department of Sociology, The Pennsylvania State University, University
Park
Jens Ludwig, Harris School of Public Policy Studies, University of Chicago, IL
Ann S. Masten, Institute of Child Development, University of Minnesota, Minneapolis
Susan E. Mayer, Harris Graduate School of Public Policy Studies, University of Chicago
Bruce S. McEwen, Harold and Margaret Milliken Hatch Laboratory of Neuroendocrinology,
The Rockefeller University, New York, NY
Andrew Meltzoff, Department of Psychology, University of Washington, Seattle
Pamela Morris, Department of Applied Psychology, The Steinhardt School of Culture, Education, and Human Development, New York University, New York
Velma McBride Murry, Peabody College, Vanderbilt University, Nashville, TN
PROGRAM LISTING
25
Food and Nutrition Board
Linda D. Meyers, Ph.D., Director
Organized: 1940
The Food and Nutrition Board (FNB) is a focal point for activities of the IOM concerned with food,
nutrition, obesity prevention, and food safety. The primary goals are
• To provide visionary leadership in the effective application of the full range of nutrition and
food sciences to improve human health;
• To contribute at national and global levels to the enhancement of child growth and development; prevention of diet-related deficiencies and chronic diseases; and improvement of
physical and cognitive function, health, and well-being;
• To decrease the incidence of foodborne diseases to improve human health nationally and
globally; and
• To apply scientific knowledge to advise on policies and approaches to eliminate, reduce, or
control the natural, inadvertent, or intentional contamination of the food supply.
Food Forum
Laura Pillsbury, Director
In 2013, the Food Forum will be celebrating its 20th anniversary. The forum was established in 1993
to allow leaders from the food industry, government, consumer interest groups, and academia to
openly discuss food-related issues in a neutral setting. Most recently, the Food Forum has facilitated
discussions to promote multisectoral cooperation and innovation around the following topics:
• Is Healthy Food Sustainable and Secure?
• The Future of Performance Standards in Food Safety: Innovation Ahead?
• The Human Microbiome, Diet, and Health
• Building Public–Private Partnerships in Food and Nutrition
• Informing Health and Food Policy Through Systematic Reviews
• The Impact of Food Safety on Global Trade: Supply Chain and Policy/Regulatory Approaches
to Import Safety
Recent Reports
2012
• Research Methods to Assess Dietary Intake and Program Participation in Child Day Care Application to the Child and Adult Care Food Program – Workshop Summary
26
PRESIDENT’S REPORT SUPPLEMENT
• Building Public-Private Partnerships in Food and Nutrition – Workshop Summary
• Alliances for Obesity Prevention: Finding Common Ground – Workshop Summary
• Accelerating Progress in Obesity Prevention: Solving the Weight of the Nation
• Ensuring Safe Foods and Drugs Through Stronger Regulatory Systems Abroad
• Nutrition and Healthy Aging in the Community – Workshop Summary
• Measuring Progress in Obesity Prevention – Workshop Report
2011
• Front-of-Package Nutrition Rating Systems and Symbols: Promoting Healthier Choices
• Updating the USDA National Breastfeeding Campaign – Workshop Summary
• Legal Strategies in Childhood Obesity Prevention – Workshop Summary
• Leveraging Food Technology for Obesity Prevention and Reduction Efforts – Workshop
Summary
• Early Childhood Obesity Prevention Policies
• Nutrition and Traumatic Brain Injury: Improving Acute and Subacute Health Outcomes in
Military Personnel • Hunger and Obesity: Understanding a Food Insecurity Paradigm – Workshop Summary
• Perspectives on Biomarker and Surrogate Endpoint Evaluation – Discussion Forum
Summary
2010
• Dietary Reference Intakes for Calcium and Vitamin D
• Planning a WIC Research Agenda – Workshop Summary
• Child and Adult Care Food Program: Aligning Dietary Guidance for All
• Providing Healthy and Safe Foods As We Age – Workshop Summary
• Examination of Front-of-Package Nutrition Rating Systems and Symbols: Phase I Report
• Enhancing Food Safety: The Role of the Food and Drug Administration (with Division of Earth
and Life Studies)
• Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (with Board on Health
Care Services and Board on Health Sciences Policy)
• Bridging the Evidence Gap in Obesity Prevention: A Framework to Inform Decision Making
• Strategies to Reduce Sodium Intake in the United States
• Perspectives from the United Kingdom and United States Policy Makers on Obesity Prevention–
Workshop Summary
PROGRAM LISTING
27
Current Activities/Studies in Progress
• Adequacy of Food Resources and SNAP Allotments
• Food Forum
• Evaluating Progress of Obesity Prevention Efforts
• Fitness Measures and Health Outcomes in Youth
• Physical Activity and Physical Education in Schools
• Standing Committee on Military Nutrition Research
• Standing Committee on Childhood Obesity Prevention
• The Human Microbiome, Diet, and Health: A Food Forum Workshop
• True Cost of Food: A Workshop
• Content coordination for HBO’s The Weight of the Nation for Kids
• Pregnancy weight gain guidelines: enhanced dissemination and derivative products (with
Board on Children, Youth, and Families)
Projects in Development
• Dietary Reference Intakes—future plans
• Assessment of Recent Evidence on Sodium Reduction and Health Outcomes (with Board on
Population Health and Public Health Practice)
• Human Health and Antibiotic Use in Agriculture (with Board on Agriculture and Natural
Resources)
• Nutrition and Food Sciences: Opportunities for Health
• Nutrition, Trauma and the Brain—Phase II
• True Cost of Food (consensus study) (with Board on Agriculture and Natural Resources)
• Chemical Contaminants in Food
• Workshop on a Developmental Approach to Childhood Obesity: The Fetal and Early Childhood Years (with Board on Children, Youth, and Families)
• A Food Forum workshop on Nutrition, Health, and Sustainability (working title) (with
Roundtable on Environmental Health Sciences, Research and Medicine)
• A Standing Committee on Childhood Obesity Prevention workshop on Emerging Issues in
Food and Beverage Marketing to Children and Youth
Board Roster
Suzanne R. Murphy (Chair), Researcher (Professor) Emeritus, University of Hawaii Cancer
Center, Honolulu, HI
28
PRESIDENT’S REPORT SUPPLEMENT
Cheryl A. M. Anderson, Assistant Scientist, Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Patsy M. Brannon, Professor, Division of Nutritional Sciences, Cornell University, Ithaca,
NY
Fergus M. Clydesdale, Department of Food Science, University of Massachusetts, Amherst,
MA
Richard J. Deckelbaum, Institute of Food and Nutrition, Columbia University, New York, NY
Sharon M. Donovan, Professor and Melissa M. Noel Endowed Chair in Nutrition and Health,
Department of Food Science and Health, University of Illinois, Urbana
Lee-Ann Jaykus, Professor, Department of Food, Bioprocessing, and Nutritional Sciences,
North Carolina State University, Raleigh
Gordon Jensen, Department of Nutritional Sciences, Pennsylvania State University, University Park
Joanne R. Lupton, Distinguished Professor, Regents Professor and University Faculty Fellow,
William W. Allen Endowed Chair in Nutrition, Texas A&M University, College Station
Susan T. Mayne, Division of Chronic Disease Epidemiology, Yale University School of Medicine, New Haven, CT
James M. Ntambi, Professor of Biochemistry, Steenbock Professor and Chair, Department of
Nutritional Sciences, University of Wisconsin, Madison
Rafael Pérez-Escamilla, Professor of Epidemiology and Public Health, Director, Office of
Community Health, Yale School of Public Health, New Haven, CT
Martin A. Philbert, Dean and Professor, School of Public Health, University of Michigan, Ann
Arbor
Mary T. Story, Professor, Division of Epidemiology and Community Health, School of Public
Health, University of Minnesota, Minneapolis
Patrick J. Stover, Division of Nutritional Sciences, Cornell University, Ithaca, NY
Connie M. Weaver, Distinguished Professor and Head, Department of Food and Nutrition,
Purdue University, West Lafayette, IN
Board on Global Health
Patrick W. Kelley, M.D., Director
Organized: 1985
Established in 1985, the Board on Global Health (BGH) is concerned with advancing the health
of populations worldwide. This involves addressing developing country health issues, enhancing
the United States’ role in global health, and addressing health issues that have implications for
PROGRAM LISTING
29
U.S. health policy. The board identifies priority issues in these areas and facilitates provision of
evidence-based guidance and recommendations to the U.S. government, international organizations, foundations, and non-governmental organizations. The board also collaborates with
medical academies in other countries, developed and developing, on health issues of mutual
concern.
Board members have broad expertise in international health and experience in a range of
countries. The board focuses on public health programs for prevention and control of disease and
disability. This includes assessment of biomedical knowledge, research, and opportunities; reduction of behavioral, socioeconomic, and environmental risks to public health; recognition and guidance on ethical issues in public health; and recognition of opportunities to apply scientific knowledge to public policy making. These activities frequently include addressing the adequacy of the
scientific base to support improvements in health and health care, along with the availability of
trained personnel, institutional capacity, and supportive partnerships and collaborations.
Forum on Microbial Threats
Eileen Choffnes, Director
The Forum on Microbial Threats was established by the IOM in 1996 to provide a structured opportunity for discussion of topics related to basic and applied research on the prevention, detection,
and management of emerging, re-emerging, and novel infectious diseases of humans, plants, and
animals and to examine critical—and possibly contentious—scientific and policy issues of shared
concern among forum members and the global public health communities. The forum’s work is
broadly categorized in the following interest areas: infectious disease surveillance and response;
diagnosis and treatment; research directions and priorities; education and training; and public
communication.
Since its creation, the issues and challenges of emerging, reemerging, and novel infectious
diseases being explored by the forum continue to be of major global public health importance. The
summary reports of forum workshops have highlighted and often anticipated some of the most
important infectious disease issues of the last decade. These activities have resulted in many workshop summary reports that are highly relevant to the issue of antimicrobial resistance.
Forum on Global Violence Prevention
Deepali Patel, Director
The Forum on Global Violence Prevention was established by the IOM and the NRC in July 2010 to
explore cross-cutting topics related to the prevention of child and elder abuse, sexual and intimate
partner violence, youth and collective violence, and self-directed violence. Since its launch in 2010,
the forum and its 30 formally appointed members have promoted multidisciplinary prevention
through public workshops on cross-cutting issues in the prevention of violence:
• Preventing Violence Against Women and Children
• Social and Economic Costs of Violence: The Value of Prevention
30
PRESIDENT’S REPORT SUPPLEMENT
• Communications and Technology for Violence Prevention
• The Contagion of Violence
The forum has a global scope, with a special emphasis on low- and middle-income countries
that highlights bidirectional learning opportunities and emphasizes an evidence-based prevention
approach.
Global Forum on Innovation in Health Professional Education
Patricia Cuff, Director
The Global Forum on Innovation in Health Professional Education was formally launched in
March 2012 to meet the challenges of the 21st century. Many of these ideas (and the inspiration for
this forum) were drawn from the RWJF-IOM Future of Nursing report and the Lancet Commission report Health Professionals for a New Century: Transforming Education to Strengthen Health
Systems in an Interdependent World. The first forum workshop, Educating for Practice: Improving
Health by Linking Education to Practice Using Interprofessional Education took place July 29–30,
2012.
The forum’s mission is to apply an ongoing, multinational, multidisciplinary approach to illuminate promising innovations for achieving reforms in the instructional and institutional spheres.
The Forum aims to have 40-50 appointed members including academic experts. It is co-chaired by
two IOM members, a physician and a nurse. The Forum will initially sponsor two major workshops
per year whose topics will be selected by the Forum membership.
Regional Innovation Clusters
In parallel with its convening function of the forum, the education forum has four affiliated,
university-based innovation clusters, one in Canada, two in Africa, and one in India. These innovation clusters each represent formal partnerships among at least three institutions: a medical school,
a nursing school, and a public health school. Approximately 2 hours of each 2-day forum workshop
will be set aside to report on and discuss the ongoing work of the four innovation clusters. This
will allow the regional clusters to share what they are learning, connect with partners around the
world, and receive assistance from the entire forum community. They will be connected to the
workshops through a videoconference link. If funds are sufficient, the workshops will also be webcast for the benefit of a global audience.
Recent Reports
2012
• Improving Food Safety Through a One Health Approach – Workshop Summary
• Communications and Technology for Violence Prevention – Workshop Summary
• Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad
• Country-Level Decision Making for Control of Chronic Diseases – Workshop Summary
PROGRAM LISTING
31
2011
• The Science and Applications of Synthetic and Systems Biology – Workshop Summary
• Social and Economic Costs of Violence – Workshop Summary
• Preventing Violence against Women and Children – Workshop Summary
• Fungal Diseases: An Emerging Threat to Human, Animal, and Plant Health – Workshop
Summary
• The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for
Integrated Intervention Strategies – Workshop Summary
2010
• Preparing for the Future of HIV/AIDS in Africa: A Shared Responsibility
• Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies –
Workshop Summary
• Strategic Approach to the Evaluation of Programs Implemented Under the Tom Lantos and
Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
• Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve
Global Health
• Infectious Disease Movement in a Borderless World: The Impact of Global Governance –
Workshop Summary
Current Activities/Studies in Progress
• Global cardiovascular disease – dissemination activities
• Forum on Microbial Threats
• Forum on Global Violence Prevention
• Global Forum on Innovation in Health Professional Education
• HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 PEPFAR II
Evaluation
• Strengthening Core Elements of Food and Drug Regulatory Systems in Developing Countries– Dissemination Activities
• Ongoing activities of the Global Forum on Health Professional Education
• Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products
32
PRESIDENT’S REPORT SUPPLEMENT
Projects in Development
• Global Roundtable on Non-Communicable Disease Control
• Forum on Public–Private Partnerships for Global Health
• Standing Committee on the Economic Transition of Health
Board Roster
Richard Guerrant (Chair), University of Virginia School of Medicine, Charlottesville
Jo Ivey Boufford (IOM Foreign Secretary), New York Academy of Medicine, New York
Claire V. Broome, Rollins School of Public Health, Emory University, Atlanta, GA
Jacquelyn C. Campbell, Johns Hopkins University School of Nursing, Baltimore, MD
Thomas J. Coates, University of California Global Health Institute, Los Angeles
Valentin Fuster, Mount Sinai School of Medicine, New York, NY
Jacob A. Gayle, Medtronic Foundation, Minneapolis, MN
Glenda E. Gray, Chris Hani Baragwanath Hospital, Witwatersrand, South Africa
Stephen W. Hargarten, Medical College of Wisconsin, Milwaukee
Olufunmilayo F. Olopade, University of Chicago, IL
James Hospedales, Pan American Health Organization/World Health Organziation,
Washington, DC
Peter J. Hotez, Sabin Vaccine Institute, Houston, TX
Clarion Johnson, Exxon Mobil, Fairfax, VA
Fitzhugh Mullan, George Washington University, Washington, DC
Guy H. Palmer, Washington State University, Pullman
Thomas C. Quinn, Johns Hopkins University School of Medicine, Baltimore, MD
Jennifer Prah Ruger, Yale University, New Haven, CT
Board on Health Care Services
Roger C. Herdman, M.D., Director
Organized: 1981
The Board on Health Care Services (HCS) oversees activities of the IOM concerned with the quality, effectiveness, organization, financing, and delivery of health care services. The board identifies
high-priority health issues and provides guidance on the conduct of studies and other projects.
Most of the board’s studies are conducted by committees appointed by the IOM and comprise a mix
PROGRAM LISTING
33
of IOM members, an occasional board member, and outside experts. The board seeks to advance
the well-being of people and communities by promoting independent, reliable scholarly analysis
and advice to government, professionals, and other members of the health industry, patients, and
the public in general.
The board’s priority areas for examination have varied slightly over the years but have been
generally consistent within the current areas:
• Quality and safety of health care
• Health information technology
• Health care organization
• Health care workforce education, practice, and financing
• Insurance coverage, financing of services, and cost control
• Human behavior and communications
• Cancer care and policy
National Cancer Policy Forum
Sharyl Nass, Director
The IOM established the National Cancer Policy Forum (NCPF) in 2005 to identify emerging highpriority policy issues in the nation’s effort to combat cancer and to examine those issues by convening activities that promote discussion about potential opportunities for action. The NCPF provides a continual focus within the IOM on cancer research and care, addressing issues in science,
clinical medicine, public health, and public policy relevant to the goal of reducing the cancer burden through prevention and by improving outcomes for those diagnosed with cancer. The NCPF
includes 30 members representing a broad range of stakeholders in the National Cancer Program,
including patient advocates, physicians, basic, translational, and clinical scientists, federal agencies, professional organizations, and the pharmaceutical industry, and has addressed a wide variety
of topics, including
• Enhancing collaborations to accelerate research and development
• Improving the quality and value of cancer and survivorship care
• The role of obesity and tobacco use in cancer incidence and mortality
• Developing tools and technologies to enhance cancer research and care
Recent Reports
2012
• Geographic Adjustment in Medicare Payment: Phase II–Implications for Access, Quality, and
Efficiency
• Informatics Needs and Challenges in Cancer Research – Workshop Summary
34
PRESIDENT’S REPORT SUPPLEMENT
• The Mental Health and Substance Use Workforce for Older Adults: In Whose Hands?
• The Role of Obesity in Cancer Survival and Recurrence – Workshop Summary
• Evolution of Translational Omics: Lessons Learned and the Path Forward
2011
• Allied Health Workforce and Services – Workshop Summary
• Breast Cancer and the Environment: A Life Course Approach (with Board on Health Sciences
Policy)
• Health IT and Patient Safety: Building Safer Systems for Better Care
• Facilitating Collaborations to Develop Combination Investigational Cancer Therapies –
Workshop Summary
• Essential Health Benefits: Balancing Coverage and Cost
• Geographic Adjustment in Medicare Payment: Phase I – Improving Accuracy, Second
Edition
• Perspectives on Essential Health Benefits – Workshop Report
• Implementing a National Cancer Clinical Trials System for the 21st Century – Workshop
Summary
• Improving Access to Oral Health Care for Vulnerable and Underserved Populations (with Board
on Children, Youth, and Families)
• Patient-Centered Cancer Treatment Planning: Improving the Quality of Oncology Care –
Workshop Summary
• Child and Adolescent Health and Health Care Quality: Measuring What Matters
• Advancing Oral Health in America (with Board on Children, Youth, and Families)
• Finding What Works in Health Care: Standards for Systematic Reviews
• Clinical Practice Guidelines We Can Trust • The National Cancer Policy Summit: Opportunities and Challenges in Cancer Research and
Care
• Nanotechnology and Oncology - Workshop Summary
• Perspectives on Biomarker and Surrogate Endpoint Evaluation - Discussion Forum
Summary
2010
• Extending the Spectrum of Precompetitive Collaboration in Oncology Research - Workshop
Summary
• Foundation for Evidence-Driven Practice: A Rapid Learning System in Cancer Care - Workshop
Summary
• Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (with Board on Health
Sciences Policy and Food and Nutrition Board)
PROGRAM LISTING
35
• A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI
Cooperative Group Program
• Future Directions for the National Healthcare Quality and Disparities Reports
• Regionalizing Emergency Care – Workshop Summary
• Policy Issues in the Development of Personalized Medicine in Oncology – Workshop
Summary
Current Activities/Studies in Progress
• National Cancer Policy Forum
• Governance and Financing of Graduate Medical Education
• Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population
• Study on Geographic Variation in Health Care Spending and Promotion of High-Value
Care
• The Role of Telehealth in an Evolving Health Care Environment: A Workshop
• Mental Health Workforce for Geriatric Populations
• Study on Geographic Adjustment Factors in Medicare Payment
Projects in Development
• Study on Family Caregiving
• Consensus study on Policy Issues in the Clinical Development and Use of Biomarkers for
Molecularly Targeted Therapies (with Board on Health Sciences Policy)
Board Roster
Gail R. Wilensky (Chair), Senior Fellow, Project Hope, Melwood, VA
Joseph R. Baker, President, Medicare Rights Center, New York, NY
Elisabeth Belmont, Corporate Counsel, MaineHealth, Portland
Robert A. Berenson, Institute Fellow, The Urban Institute, Washington, DC
Lisa Bero, Professor, Department of Clinical Pharmacy, School of Pharmacy and Institute for
Health Policy Studies, School of Medicine, University of California, San Francisco
David Blumenthal, Samuel O. Thier Professor of Medicine, Harvard Medical School;
Professor of Health Care Policy, Massachusetts General Hospital, Mongan Institute for
Health Policy, Boston
Stuart Butler, Distinguished Fellow and Director, Center for Policy Innovation, The Heritage
Foundation, Washington, DC
36
PRESIDENT’S REPORT SUPPLEMENT
Jon B. Christianson, James A. Hamilton Chair in Health Policy and Management Division of Health Policy and Management School of Public Health, University of Minnesota,
Minneapolis
Jack Ebeler, Principal, Health Policy Alternatives, Inc. Washington, DC
Robert S. Galvin, Chief Executive Officer, Equity Healthcare; Executive Director, Corporate
Private Equity, The Blackstone Group , New York, NY
Rebekah E. Gee, Assistant Professor, Louisiana State University (LSU) Schools of Medicine
and Public Health; Birth Outcomes Director, Louisiana Department of Health and Hospitals, LSU School of Public Health, Baton Rouge
Carmen R. Green, Professor of Anesthesiology, Obstetrics and Gynecology, and Health Management and Policy, Schools of Medicine and Public Health, University of Michigan Health
System, Ann Arbor
Mareasa R. Isaacs, Executive Director, National Alliance Of Multi-Ethnic Behavioral Health
Associations, Bethesda, MD
Brent C. James, Vice President for Medical Research and Executive Director of Institute for
Health Care Delivery Research, Intermountain Health Care, Salt Lake City, UT
Charles N. Kahn III, President and Chief Executive Officer, Federation Of American
Hospitals, Washington, DC
Elizabeth A. McGlynn, Director, Kaiser Permanente Center for Effectiveness & Safety
Research, Oakland, CA
Cynthia D. Mulrow, Clinical Professor of Medicine, University of Texas Health Science
Center at San Antonio, Senior Deputy Editor, Annals of Internal Medicine
Mary D. Naylor, Director, NewCourtland Center for Transitions and Health, Marian S. Ware
Professor in Gerontology, National Program Director, Interdisciplinary Nursing Quality
Research Initiative, University of Pennsylvania, Philadelphia
Alan Weil, Executive Director, National Academy for State Health Policy, Portland, ME
Board on Health Sciences Policy
Andrew Pope, Ph.D., Director
Organized: 1977
The Board on Health Sciences Policy oversees and guides a program of activities that is intended
to encourage and sustain the continuous vigor of the basic biomedical and clinical research enterprises needed to ensure and improve the health of the public. In conducting these activities, consideration is given to the ethical, legal, and social contexts of scientific and technologic advances
and to the balance between scientific opportunities and public needs.
PROGRAM LISTING
37
The goals of the Board on Health Sciences Policy are to
• Foster the emerging fields of research in the health and biomedical sciences;
• Strengthen the role of science in policy and decision making;
• Promote and improve the education of health and research professionals and of the
general public;
• Ensure an adequate workforce in biomedical and clinical research; and
• Address issues in biomedical ethics.
To accomplish these goals, the board helps shape the portfolio of projects by continuously
monitoring issues in health policy and identifying emerging problems. Board members oversee the
implementation of ideas and proposals and assist in ensuring the focus and purpose of sponsored
projects through periodic review of study progress at board meetings and as official members on
board-sponsored studies. Board members also assist in the dissemination of study findings and
monitor the impact of sponsored studies.
Forum on Drug Discovery, Development, and Translation
Anne Claiborne, J.D., M.P.H., Director
The Forum on Drug Discovery, Development, and Translation brings together thought leaders and
stakeholders in government, academia, industry, foundations, and patient advocacy with an interest in issues related to drug discovery, development, and translation. The forum convenes several
times each year to identify and discuss key problems and strategies in the discovery, development,
and translation of drugs. To supplement the perspectives and expertise of its members, the forum
also holds public workshops and commissions and fosters papers to engage a wide range of experts,
members of the public, and the policy community. The activities of the forum are determined by
its members, focusing on five major themes: (1) the approach to drug development; (2) strengthening the scientific basis of drug regulation; (3) transforming research and fostering collaborative
research; (4) developing drugs for rare and neglected diseases and addressing urgent global health
problems; and (5) promoting public understanding of drug development.
Over the past several years, the forum has been engaged in three major long-term initiatives:
Advancing Regulatory Science; Transforming Clinical Trials; and Addressing the Global Neglected
Disease Multidrug-Resistant Tuberculosis.
Forum on Neuroscience and Nervous System Disorders
Bruce Altevogt, Ph.D., Director
The Forum on Neuroscience and Nervous System Disorders focuses on building partnerships to
further understand the brain and nervous system disorders in their structure and function, as well
as effective clinical prevention and treatment strategies. The forum concentrates on six themes:
nervous system disorders, mental illness and addiction, genetics of nervous system disorders, cog-
38
PRESIDENT’S REPORT SUPPLEMENT
nition and behavior, modeling and imaging, and ethical and social issues. It serves to educate the
public, press, and policy makers regarding these issues. The forum brings together leaders from
private-sector sponsors of biomedical and clinical research, federal agencies sponsoring and regulating biomedical and clinical research, foundations, the academic community, and consumers.
The forum sponsors workshops for members and the public to discuss approaches to resolving
key challenges identified by forum members. It strives to enhance understanding of research and
clinical issues associated with the nervous system among the scientific community and the general
public, and provide a mechanism to foster partnerships among stakeholders.
Roundtable on Translating Genomic-Based Research for Health
Adam Berger, Ph.D., Director
The Roundtable on Translating Genomic-Based Research for Health brings together leaders from
academia, industry, government, foundations, associations, and patient and consumer representatives who have a mutual interest in addressing the issues surrounding the translation of genomicbased research. The purpose of the roundtable is to explore and implement strategies for improving health through the translation of genomic and genetic research findings into medicine, public
health, education, and policy. Priorities and areas of emphasis for the roundtable include: (1) issues
related to the translation of genomics into medicine and public health; (2) issues related to the
evolving requirements for the health professional community and the need to be able to understand and responsibly apply genomics to medicine and public health; and (3) ethical, legal, and
social issues such as the potential for misuse of genetic information, the medical implications for
family members; and the rights of an individual, family, or community to control the use and dissemination of genetic information. To achieve its objectives, the roundtable conducts structured
discussions, workshops, and symposia and publishes workshop summaries.
The roundtable has developed several initiatives around the topics of clinical practice and
public health, drug development informed by genomics and genetics, diagnostic applications for
genomics, and emerging issues to guide the roundtable as it moves forward.
Forum on Medical and Public Health Preparedness for Catastrophic Events
Bruce Altevogt, Ph.D., Director
The Forum on Medical and Public Health Preparedness for Catastrophic Events serves to foster
dialogue among stakeholders and provide ongoing opportunities to confront and discuss issues of
mutual interest and concern. The forum provides a neutral venue for broad-ranging policy discussions that serve to facilitate coordination and cooperation among public and private stakeholders in developing and enhancing the nation’s medical and public health preparedness. More specifically, the forum provides a catalyst for voluntary public/private collaboration on topics where
there is synergy among potential partners; helps define the scope of the field and thus sets the stage
for future policy action; brings ongoing attention and visibility to important preparedness issues;
explores new approaches for resolving problem areas; and elevates the general understanding and
visibility of medical and public health preparedness in the broader research, public policy, and
other appropriate communities.
PROGRAM LISTING
39
The forum is self-governing; i.e., the forum membership identifies the topics that it wishes to
address, and with assistance from staff, develops meeting agendas and identifies workshop topics.
As a result, topics span a broad range of issues in research, policy, and practice. Initial attention is
being given to the following broad topic areas: medical surge capacity, disaster preparedness training, communication and distribution, psychological and community resilience, and research and
evaluation.
Forum on Aging, Independence and Disability
Tracy A. Lustig, D.P.M., M.P.H., Director
The IOM, in collaboration with the Division on Behavioral and Social Science and Education of the
National Research Council, has formed a new Forum on Aging, Disability, and Independence that
fosters dialogue and confronts issues of mutual interest and concern within the long-term services
and supports system. The forum will highlight capacities in which aging and disability network
coordination is strong; examine the historic challenges faced in aligning the aging and disability
networks; define the scope of the challenges; explore new approaches for resolving problem areas;
elevate the visibility and perspectives of the many stakeholders; and set the stage for future policy
actions.
The forum is self-governing. That is, the forum membership identifies the specific topics
that it wishes to address, and with assistance from staff, develops meeting agendas, commissions
papers, and identifies workshop topics. Topics will span a broad range of issues such as personcentered planning, self-direction, workforce education and training, health care and personal care
workforces, quality measurement, health disparities, research, and assistive technologies. The
forum’s first workshop will be held in December 2012, and will focus on technologies that foster
independence, participation, and healthy aging.
Standing Committee on Health Threats Resilience
Bruce Altevogt, Ph.D., Director
The Standing Committee on Health Threats Resilience is sponsored by the Department of Homeland Security’s Office of Health Affairs. The standing committee discusses issues related to shortand long-term strategic planning and includes experts in emergency management, emergency
medical services, emergency preparedness and response, intelligence, public health and medicine,
community resilience, economic development, and sociocultural sciences. The standing committee maintains surveillance of the field, discusses planning and program development efforts, and
serves as a focal point within the IOM and National Academies for discussions and potential ad
hoc studies related to (1) community resilience against health threats—including issues relevant
to preparedness, community engagement, and communications; (2) health security—the interface
with intelligence, infrastructure and security, and health resilience; (3) emergency response and
recovery activities and support of operational medicine; and (4) capacity and gaps in the capability
of federal, state, and local authorities to respond to catastrophic health events, including events
related to food, agriculture, human health, and animal health issues. In this process, the stand-
40
PRESIDENT’S REPORT SUPPLEMENT
ing committee may provide a public venue for communication among government, the academic
community, and the private sector, as well as other relevant stakeholders involved in emergency
preparedness and emergency response services. Further, as needed, the standing committee will
be involved in the planning, development, and oversight of related ad hoc activities undertaken by
separately appointed committees operating under its auspices. Standing committee discussions
have led to workshops that have explored topics related to workforce resilience and biosurveillance.
Standing Committee on Credentialing Research in Nursing
Cathy Liverman and Andrea Schultz, Co–Study Directors
The IOM will convene a standing committee for the American Nurses Credentialing Center. The
standing committee will discuss issues related to research on credentialing of nurses and organizations, including short- and long-term strategic planning. The standing committee will maintain
surveillance of the field, discuss planning and program development, and serve as a focal point for
discussions and potential ad hoc studies requested by the sponsor and approved by the IOM and
the National Academies. Topics that may be addressed by the standing committee or by sponsored
workshops and future studies by IOM committees include
• emerging priorities for nursing credentialing research;
• research methodologies and measures relevant to nursing credentialing research;
• the impact of individual and organizational credentialing in nursing on improving healthcare performance, quality, and outcomes.
Committee on Aerospace Medicine and the Medicine of Extreme Environments
Cathy Liverman and Andrea Schultz, Co–Study Directors
The IOM standing Committee on Aerospace Medicine and the Medicine of Extreme Environments
coordinates with National Aeronautics and Space Administration’s Office of the Chief Health and
Medical Officer to become informed about existing conditions and emerging issues related to medical care in space and define prospective activities (such as studies or analyses of medical needs
and/or approaches to addressing those needs) to be conducted at the IOM. The standing committee serves as a focal point for consideration of issues related to the practice of medicine during
space travel. The standing committee considers relevant scientific, technical, and policy issues,
including the development of optimal aerospace medicine health care as an evolving multidisciplinary and international enterprise, health maintenance and care policies related to aerospace
medicine, clinical research requirements and clinical strategies, and other relevant issues. Ad hoc
committees are established to conduct studies as needed and as approved by the IOM and the
National Academies.
PROGRAM LISTING
41
Committee on Personal Protective Equipment for Workplace Safety and Health
Cathy Liverman and Andrea Schultz, Co-Study Directors
The standing Committee on Personal Protective Equipment for Workplace Safety and Health
addresses scientific and technical issues relevant to the development, certification, deployment,
and use of personal protective equipment, standards, and related systems to ensure workplace
safety and health. This standing committee is supported by the National Personal Protective Technology Laboratory at the National Institute for Occupational Safety and Health.
Standing Committee on Family Planning
Adrienne Stith Butler, Ph.D., Director
The Standing Committee on Family Planning is sponsored by the Department of Health and
Human Services Office of Family Planning (OFP). The standing committee has followed up on
issues addressed in the 2009 IOM report, A Review of the HHS Family Planning Program: Mission,
Management, and Measurement of Results, as well as identified emerging issues in this field. The
standing committee provides a forum for discussion of scientific, workforce, health services, and
education issues relevant to family planning.
The committee maintains surveillance of the field, discusses planning and program development efforts, and serves as a focal point for discussions and potential ad hoc studies requested by
OFP and approved by the IOM and the National Academies. Specific topics addressed at meetings
of the standing committee have included workforce planning; the role of family planning/reproductive health in health care reform; improving data collection on program performance; communication and transparency; and strategic planning for moving the Title X Program forward.
Recent Reports
2012
• Genome-Based Therapeutics: Targeted Drug Discovery and Development – Workshop
Summary
• Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the
Cures Acceleration Network – Workshop Summary
• Post-Incident Recovery Considerations of the Health Care Service Delivery Infrastructure –
Workshop Summary
• A Review of NASA’s Human Research Program’s Scientific Merit Assessment Process – Letter
Report
• International Animal Research Regulations: Impact on Neuroscience Research – Workshop
Summary
• Public Engagement on Facilitating Access to Antiviral Medications and Information in an
Influenza Pandemic– Workshop Series Summary
42
PRESIDENT’S REPORT SUPPLEMENT
• Facing the Reality of Drug-Resistant Tuberculosis: Challenges and Potential Solutions in India
– Summary of a Joint Workshop
• Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an
Agenda for 2020 – Workshop Summary
• Building a Resilient Workforce: Opportunities for the Department of Homeland Security –
Workshop Summary
• Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad (with
Board on Global Health)
• Epilepsy Across the Spectrum: Promoting Health and Understanding
• Crisis Standards of Care: A Systems Framework for Catastrophic Disaster Response
• Genome-Based Diagnostics: Clarifying Pathways to Clinical Use – Workshop Summary
• Safe and Effective Medicines for Children: Pediatric Studies Conducted Under BPCA and
PREA
• Alzheimer’s Diagnostic Guideline Validation: Exploration of Next Steps – Workshop
Summary
• Barriers to Integrating Crisis Standards of Care Principles into International Disaster Response
Plans – Workshop Summary
• Sex-Specific Reporting of Scientific Research - Workshop Summary (with Board on Population
Health and Public Health Practice)
2011
• Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development –
Workshop Summary
• Chimpanzees in Biomedical and Behavioral Research: Assessing the Necessity
• Breast Cancer and the Environment: A Life Course Approach
• Information Sharing and Collaboration: Applications to Integrated Biosurveillance –
Workshop Summary
• Integrating Large-Scale Genomic Information into Clinical Practice – Workshop Summary
• Public Engagement and Clinical Trials: New Models and Disruptive Technologies – WorkshopSummary
• Incorporating Occupational Information in Electronic Health Records: Letter Report
• Prepositioning Antibiotics for Anthrax
• Occupational Health Nurses and Respiratory Protection: Improving Education and Training –
Letter Report
• Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and
Research
• Advancing Regulatory Science for Medical Countermeasure Development – Workshop Summary
PROGRAM LISTING
43
• Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System – A
Workshop
• Generating Evidence for Genomic Diagnostic Test Development – Workshop Summary
• The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective:
Summary of a Joint Workshop
• The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa: Global and Local
Challenges and Solutions – Workshop Summary
• Preparedness and Response to a Rural Mass Casualty Incident – Workshop Summary
• Preventing Transmission of Pandemic Influenza and Other Viral Respiratory Diseases: Personal Protective Equipment for Healthcare Personnel – Update 2010
• Perspectives on Biomarker and Surrogate Endpoint Evaluation – Discussion Forum Summary
(with Board on Health Care Services and Food and Nutrition Board)
2010
• Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development– Workshop Summary
• Transforming Clinical Research in the United States: Challenges and Opportunities– Workshop
Summary
• Building a National Framework for the Establishment of Regulatory Science for Drug Development – Workshop Summary
• The Value of Genetic and Genomic Technologies – Workshop Summary
• Challenges and Opportunities in Using Residual Newborn Screening Samples for TranslationalResearch – Workshop Summary
• Future Opportunities to Leverage the Alzheimer’s Disease Neuroimaging Initiative – A Workshop Summary
• Sex Differences and Implications for Translational Neuroscience Research – A Workshop
Summary
• Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa: Reducing the Treatment Gap, Increasing Quality of Care – Workshop Summary
• Certifying Personal Protective Technologies: Improving Worker Safety
• Medical Countermeasures Dispensing: Emergency Use Authorization and the Postal Model –
Workshop Summary
• The 2009 H1N1 Vaccination Campaign – Summary of a Workshop Series
• Rare Diseases and Orphan Products: Accelerating Research and Development
• Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
• CNS Clinical Trials: Suicidality and Data Collection – Workshop Summary
• The Public Health Emergency Medical Countermeasures Enterprise: Innovative Strategies to
Enhance Products from Discovery Through Approval – Workshop Summary
44
PRESIDENT’S REPORT SUPPLEMENT
• Medical Surge Capacity – Workshop Summary
• BioWatch and Public Health Surveillance: Evaluating Systems for the Early Detection of Biological Threats (with Board on Life Sciences and Board on Chemical Sciences and Technology)
Current Activities/Studies in Progress
• Review of California Institute for Regenerative Medicine
• Review of the Clinical and Translational Science Awards Program at the National Center for
Advancing Translational Sciences
• Committee on Department of Homeland Security Workforce Resilience
• Committee on Health and Medical Infrastructure Needs for the Department of Health and
Human Services
• Forum on Drug Discovery, Development, and Translation
• Forum on Neuroscience and Nervous System Disorders
• Roundtable on Translating Genomic-Based Research for Health
• Forum on Medical and Public Health Preparedness for Catastrophic Events
• Forum on Aging, Independence and Disability
• Standing Committee on Health Threats Resilience
• Standing Committee on Credentialing Research in Nursing
• Committee on Aerospace Medicine and the Medicine of Extreme Environments
• Committee on Personal Protective Equipment for Workplace Safety and Health
• Standing Committee on Family Planning
Projects in Development
• Treatment of Cardiac Arrest
• Cognitive Aging: Translating Science into Prevention and Care
• Prescription Drug Abuse
• Regenerative Medicine Forum
• Forum on Engineering and Biomedical Technology
• Personalized Medicine (Policy Issues in Clinical Development and Use of Biomarkers for
Molecularly Targeted Therapies)
• Epilepsy Forum
• Mental and Behavioral Health
• Uniformed Services University of the Health Sciences/Agriculture and Food Research
Initiative “Radiobiology” (with Board on the Health of Select Populations)
PROGRAM LISTING
45
Board Roster
C. Thomas Caskey (Chair), Baylor University, Waco, TX
Eli Y. Adashi, Brown University, Providence, RI
Robert M. Califf, Duke University Medical Center, Durham, NC
Dennis Choi, The Simons Foundation, New York, NY
Kathleen A. Dracup, University of California, San Francisco
Michael Ehlers, Pfizer, Inc., Cambridge, MA
Naomi Gerber, George Mason University, Fairfax, VA
Linda C. Giudice, University of California, San Francisco
Lewis R. Goldfrank, New York University School of Medicine, New York
Lawrence O. Gostin, Georgetown University Law Center, Washington, DC
Steven E. Hyman, The Broad Institute of Harvard and MIT, Cambridge, MA
Paul E. Jarris, Association of State and Territorial Health Officials, Arlington, VA
Jeffrey Kahn, Johns Hopkins University, Baltimore, MD
Harry T. Orr, University of Minnesota, Minneapolis
Sharon Terry, Genetic Alliance, Washington, DC
Reed V. Tuckson, UnitedHealth Group, Minnetonka, MN
Keith A. Wailoo, Rutgers, The State University of New Jersey, New Brunswick
Clyde Yancy, Baylor University Medical Center, Dallas, TX
Board on the Health of Select Populations
(Formerly the Board on Military and Veterans Health)
Rick Erdtmann, M.D., M.P.H., Director
Organized: 2006
The Board on the Health of Select Populations was established in February 2009 to examine health
needs and health policies surrounding a broad range of discrete populations. The board concentrates on significant health concerns that may affect groups of individuals categorized and defined
by common occupation, environment, health condition or characteristics, or a shared exposure to
a unique health risk.
The board continues to build on previous work on the health of members of the military and
military veterans conducted by its predecessor, the Board on Military and Veterans Health, and the
Medical Follow-Up Agency (MFUA). MFUA now operates under the Board on the Health of Select
Populations.
46
PRESIDENT’S REPORT SUPPLEMENT
Recent Reports
2012
• Substance Use Disorders in the U.S. Armed Forces
• Treatment of Posttraumatic Stress Disorder in Military and Veteran Populations: Initial Assessment
2011
• Long-term Health Consequences of Exposure to Burn Pits in Iraq and Afghanistan
• Cognitive Rehabilitation Therapy for Traumatic Brain Injury: Evaluating the Evidence
• Veterans and Agent Orange: Update 2010
• Blue Water Navy Vietnam Veterans and Agent Orange Exposure
• The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better
Understanding
2010
• HIV and Disability: Updating the Social Security Listings
• Cardiovascular Disability: Updating the Social Security Listings
• Gulf War and Health: Volume 8–Health Effects of Serving in the Gulf War
• Returning Home from Iraq and Afghanistan: Preliminary Assessment of Readjustment Needs of
Veterans, Service Members, and Their Families
• Provision of Mental Health Counseling Services Under TRICARE
• The Utility and Proximity-Based Herbicide Exposure Assessment in Epidemiologic Studies of
Vietnam Veterans
Current Activities/Studies in Progress
• Assessment of Ongoing Efforts in the Treatment of PTSD
• Initial Assessment of Readjustment Needs of Military Personnel, Veterans, and Their
Families: Phase 2
• Health Effects in Vietnam Veterans of Exposure to Herbicides (Ninth Biennial Update)
• Prevention, Diagnosis, Treatment and Management of Substance Use Disorders in the U.S.
Armed Forces
• Review of the Appropriate Use of AFIP’s Tissue Repository Following its Transfer to the
Joint Pathology Center
• Evaluation of the Lovell Federal Health Care Center Merger
• Gulf War and Health: Treatment of Chronic Multisymptom Illness
PROGRAM LISTING
47
• Review of the Department of Labor’s Site Exposure Matrix Database
• Gulf War and Health: Long-Term Effects of Blast Exposure
• Standing Committee of Medical Experts to Assist Social Security on Disability Issues
Projects in Development
• The Assessment of Childhood Disability for the Social Security Administration
• Research Directions in Human Biological Effects of Low-Level Ionizing Radiation
• Prisoner Health and Its Implication for the Public’s Health
• Standing Committee on Health and Medicine for the Assistant Secretary of Defense for
Health Affairs
• Military Health System Longitudinal Capacity Needs to Care for Wounded, Ill, or Injured
Service members and Veterans Serving in Operation Enduring Freedom, Operation Iraqi
Freedom, and Operation New Dawn
Board Roster
Robert B. Wallace (Chair), University of Iowa College of Public Health, Iowa City
George K. Anderson, Association of Military Surgeons of the United States, Bethesda, MD
Kathleen Brady, South Carolina Clinical and Translational Research Institute, Charleston
John C. S. Breitner, McGill University, Montreal, Quebec
Jonathan Davidson, Duke University, Durham, NC
Walter R. Frontera, Puerto Rico Clinical and Translational Research Consortium, San
Juan
Timothy R. Gerrity, Alliance for Commercialization of Technology, Redlands, CA
Gregory C. Gray, University of Florida, Gainesville
Kurt Kroenke, Indiana University School of Medicine, Indianapolis
Stanley M. Lemon, University of North Carolina, Chapel Hill
M. Jeanne Miranda, University of California, Los Angeles
Frances Murphy, Health Care Independent Consultant, Silver Spring, MD
Kenneth Olden, U.S. Environmental Protection Agency, Washington, DC
Jennifer D. Peck, University of Oklahoma Health Sciences Center, Oklahoma City
Carol K. Redmond, University of Pittsburgh, Pittsburgh
George W. Rutherford, University of California, San Francisco
48
PRESIDENT’S REPORT SUPPLEMENT
Medical Follow-Up Agency
David Butler, Ph.D., Director
Organized: 1946
The Medical Follow-Up Agency (MFUA) is an organizational element of the IOM’s Board on the
Health of Select Populations.
The Medical Follow-Up Agency was founded shortly after World War II at the urging of
Dr. Michael DeBakey, then a colonel in the Office of the Army Surgeon General. In its early years,
the program consisted predominantly of clinical follow-up studies in which veterans were examined for after-effects of World War II injuries and diseases.
MFUA now conducts a variety of epidemiological research studies and collaborates with
qualified researchers from diverse backgrounds to obtain and analyze records data.
Recent Publications
• Long-Term Health Effects of Participation in Project SHAD I (Shipboard Hazard and
Defense)
Recent Journal Publications
Rubio-Tapia, A., et al. 2009. Increased prevalence and mortality in undiagnosed celiac disease.
Gastroenterology 137(1):88-93.
Trumbetta, S. L., et al. 2007. Marriage and genetic variation across the lifespan: Not a steady
relationship? Behavior Genetics 37(2):362-375.
Miller, R. N., et al. 2006. Patterns of health care seeking of Gulf War registry members prior to
deployment. Military Medicine 171(5):370-375.
MFUA’s complete bibliography through 2009 may be found at: http://www.iom.edu/AboutIOM/Leadership-Staff/Boards/Medical-Follow-Up-Agency.aspx
Current Activities/Studies in Progress
• Air Force Health Study (Ranch Hand) Research Management Program
• Shipboard Hazard and Defense II
• Studies of U.S. Veteran Twins in the World War II Registry
• The Medical Follow-Up Agency Cohort Catalog
Projects in Development
• Mortality Status of World War II Twins
PROGRAM LISTING
49
• High-Density Alcohol Drinking and Long-Term Death Risk: A Twins Perspective
• Multiple Sclerosis in Vietnam and Gulf War–Era Veterans
Advisory Committee Roster
Kenneth Olden (Chair), U.S. Environmental Protection Agency, Washington, DC
John C. S. Breitner, McGill University, Montreal, Quebec
Gregory C. Gray, University of Florida, Gainesville
Kurt Kroenke, Indiana University School of Medicine, Indianapolis
Frances Murphy, Health Care Independent Consultant, Silver Spring, MD
Jennifer D. Peck, University of Oklahoma Health Sciences Center, Oklahoma City
Carol K. Redmond, University of Pittsburgh, Pittsburgh
Board on Population Health and Public Health Practice
Rose Marie Martinez, Sc.D., Director
Organized: 1981
The Board on Population Health and Public Health Practice is broadly concerned with promoting
the health of the public—physical, mental, and social—particularly through population-based interventions. The board examines and develops strategies for disease prevention, taking into account
the multiple factors affecting health—genetic endowment, social and environmental conditions,
individual behavior (including tobacco use, alcohol consumption, diet, and exercise) and personal preventive services. The board addresses the science base for such interventions, the public
health infrastructure, and the education and supply of health professionals necessary for carrying
them out.
The board has an ongoing program of studies on public health infrastructure, women’s and
children’s health, immunization, AIDS and sexually transmitted diseases, and environmental and
occupational health. In particular, the board has identified three priority areas that fall within a broad
focus covering both preventive services and public health functions to emphasize in its work:
• reexamining public health capacities and responsibilities to meet public health challenges at
the federal, state, and local level;
• community interventions to promote healthful behavior; and
• occupational and environmental health issues.
50
PRESIDENT’S REPORT SUPPLEMENT
Roundtable on Environmental Health Sciences, Research, and Medicine
Christine Coussens, Director
The Roundtable on Environmental Health Sciences, Research, and Medicine was established in
1998 as a convening mechanism for individuals from the academic, industrial, nongovernmental,
and governmental perspectives to meet and discuss sensitive and difficult environmental health
issues of mutual interest in a neutral setting. Since its inception, the roundtable has addressed
current and emerging issues in environmental health through discussions related to the state of
the science, research gaps, and policy implications. Current topics include the health implications
of
• hydrofracking and energy policies;
• ecosystem services;
• agriculture; and
• sustainable development.
The roundtable has a national focus, but recognizes global, regional, and local implications.
Health Literacy Roundtable
Lyla Hernandez, Director
The Roundtable on Health Literacy was established in 2006 to discuss challenges facing health
literacy research and practice and identify approaches to promote health literacy through mechanisms and partnerships in both the public and private sectors. Since its first workshop in 2006, the
roundtable has held 14 workshops and published 11 reports on such topics as improved medication
labeling, use of electronic health records, and integration of health literacy with disparities reduction and quality improvement. The roundtable has established working groups to explore and devvelop activities addressing health literacy and health linsurance reform, international health literacy, public health literacy, and what makes an organization health literate.
Addressing health literacy is critical to transforming health care quality. Goals for safe,
patient-centered, and equitable care cannot be achieved if consumers cannot access services or
make informed health care decisions.
Roundtable on the Promotion of Health Equity and the Elimination of Health
Disparities
Karen Anderson, Director
The IOM convened the Roundtable on the Promotion of Health Equity and the Elimination of
Health Disparities in 2007 to stimulate action, further the development of programs and strategies, promote health equity, and foster the emergence of leadership. With the publication of several
seminal IOM reports documenting the problem of health disparities in the early 2000s (for exam-
PROGRAM LISTING
51
ple, Unequal Treatment in 2003 and In the Nation’s Compelling Interest in 2004), the roundtable
was created to continue the focus on eliminating health disparities. The roundtable, in its focus on
underserved populations, focuses on understanding the social determinants of health that underlie health disparities.
Recent Reports
2012
• How Far Have We Come in Reducing Health Disparities? Progress Since 2000 – Workshop
Summary
• How Can Health Care Organizations Become More Health Literate? – Workshop Summary
• Ranking Vaccines: A Prioritization Framework – Phase I: Demonstration of Concept and a
Software Blueprint
• Ethical and Scientific Issues in Studying the Safety of Approved Drugs
• For the Public’s Health: Investing in a Healthier Future
• Primary Care and Public Health: Exploring Integration to Improve Population Health
• Monitoring HIV Care in the United States: Indicators and Data Systems.
• Facilitating State Health Exchange Communication Through the Use of Health Literate
Practices – Workshop Summary
• Living Well with Chronic Illness: A Call for Public Health Action
• Sex-Specific Reporting of Scientific Research – Workshop Summary
2011
• Scientific Standards for Studies on Modified Risk Tobacco Products
• Improving Health Literacy Within a State – Workshop Summary
• Promoting Health Literacy to Encourage Prevention and Wellness – Workshop Summary
• State and Local Policy Initiatives to Reduce Health Disparities – Workshop Summary
• Adverse Effects of Vaccines: Evidence and Causality
• Medical Devices and the Public’s Health: The FDA 510(k) Clearance Process at 35 Years
• A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases
• Clinical Preventive Services for Women: Closing the Gaps
• Health Literacy Implications for Health Care Reform – Workshop Summary
• For the Public’s Health: Revitalizing Law and Policy to Meet New Challenges
• Climate Change, the Indoor Environment, and Health
• Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and
Other Tick-Borne Diseases: The Short-Term and Long-Term Outcomes – Workshop Report
52
PRESIDENT’S REPORT SUPPLEMENT
• HIV Screening and Access to Care: Health Care System Capacity for Increased HIV Testing and
Provision of Care
• Leading Health Indicators for Healthy People 2020 – Letter Report
• Innovations in Health Literacy Research – Workshop Summary
• HIV Screening and Access to Care: Exploring the Impact of Policies on Access to and Provision
of HIV Care
2010
• For the Public’s Health: The Role of Measurement in Action and Accountability
• The Safe Use Initiative and Health Literacy – A Workshop Summary
• Public Health Effectiveness of the FDA 510(k) Clearance Process: Measuring Postmarket
Performance and Other Select Topics – Workshop Report
• Research Priorities for Assessing Health Effects from the Gulf of Mexico Oil Spillm – Letter
Report
• Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and
Innovation – Workshop Report
• Review of the Proposal for the Gulf Long-Term Follow-Up Study: Highlights from the September
2010 Workshop – Workshop Report
• Women’s Health Research: Progress, Pitfalls and Promise
• HIV Screening and Access to Care: Exploring Barriers and Facilitators to Expanded HIV
Testing
• Ethical Issues in Studying the Safety of Approved Drugs – Letter Report
• Demographic Changes, A View from California: Implications for Framing Health Disparities –
Workshop Summary
• A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension
• Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B
and C
Current Activities/Studies in Progress
• Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule
• Environmental Decision Making Under Uncertainty
• Developing a Decision-Support Tool for Prioritizing New Vaccines
• Public Health Strategies to Improve Health
• Review of Data Systems for Monitoring HIV/AIDS Care
PROGRAM LISTING
53
• Roundtable on Environmental Health Sciences, Research, and Medicine
• Health Literacy Roundtable
• Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities
• Valuing Community-Based, Nonclinical Prevention Programs
Projects in Development
• Roundtable on Population Health Improvement
• Electronic Health Record Meaningful Use Domains and Measures to Capture Social
Determinants
• Infrastructure for Estimating Core Indicators of HIV Infection, Diagnosis, and Access to
Care and Supportive Services
• Integrating Behavioral and Psychosocial Care into the Evolving Health Care System
Board Roster
Ellen Wright Clayton (Chair), Vanderbilt University, Nashville, TN
Margarita Alegría, Cambridge Health Alliance, Sommerville, MA
Susan M. Allan, University of Washington, Seattle
Georges C. Benjamin, American Public Health Association, Washington, DC
Bobbie A. Berkowitz, Columbia University School of Nursing, New York, NY
David R. Challoner, University of Florida, Gainesville
R. Alta Charo, University of Wisconsin–Madison
Jose Julio Escarce, University of California, Los Angeles, Department of Medicine, Division
of General Internal Medicine and Health Services Research
Alvin D. Jackson, Ohio Department of Health, Fremont
Matthew W. Kreuter, Washington University in Saint Louis, MO
Howard Markel, University of Michigan Medical School, Ann Arbor
Elena O. Nightingale, National Academies of Science (Emerita), Washington, DC
Margaret E. O’Kane, National Committee for Quality Assurance, Washington, DC
Susan L. Santos, University of Medicine and Dentistry, New Jersey, Piscataway
Martin Jose Sepulveda, International Business Machines Corporation, Sommers, NY
Samuel So, Stanford University, CA
Antonia M. Villarruel, University of Michigan School of Nursing, Ann Arbor
Paul J. Wallace, The Lewin Group, Falls Church, VA
54
PRESIDENT’S REPORT SUPPLEMENT
Health Policy Educational Programs and Fellowships
Marie E. Michnich, Dr.P.H., Director
Organized: 1973
The Health Policy Educational Programs and Fellowships (HPEPF) office serves as the program
office for four national health policy fellowship programs: the Robert Wood Johnson Foundation
(RWJF) Health Policy Fellows; the IOM/American Nurses Foundation (ANF)/American Academy
of Nursing (AAN)/American Nurses Association (ANA) Distinguished Nurse Scholar in Residence;
the IOM Anniversary Fellows; and the Food and Drug Administration (FDA) Tobacco Regulatory
Science Fellowship.
The first and the oldest program, the RWJF Health Policy Fellows, is now in its 39th year of
operation. Exceptional midcareer health professional and behavioral and social scientists actively
participate in and contribute to the policy process at the federal level during a 12-month residential experience in Washington, DC. These fellows remain in high demand and continue to receive
the most prominent federal health policy placements in both Congress and presidential administrations. Since 1973, HPEPF has been responsible for the recruitment, selection, orientation,
and placement of Health Policy Fellows and has overseen the fellowships of 245 recipients. IOM
staff leadership, particularly the board directors, contributes to the orientation and placement and
serves as a resource for the fellows throughout their experience. The priority areas of emphasis
for this program are (1) to continue to seek out qualified minority applicants, (2) to maintain a high
number of qualified applicants, and (3) to promote political balance in both recruitment and placement of the fellows.
This office also hosts the Distinguished Nurse Scholar-in-Residence, initiated in 1992 and
supported by the AAN, the ANF, and the ANA. This residential program is designed to assist nurse
leaders in playing a more prominent role in health policy development at the national level through
a 1-year program of orientation and study at the IOM. The scholar produces a report as a result of
working on a current IOM initiative related to his/her area of expertise. The Distinguished Nurse
Scholar-in Residence for 2012-2013 is Marla Salmon, an IOM member and the immediate past dean
of the University of Washington School of Nursing. She brings expertise to the IOM from her numerous leadership roles in nursing, public health, and domestic and global health workforce capacity
building. Salmon’s work will look specifically at three areas of policy and scholarship;: (1) global
nursing workforce capacity building, (2) women’s development aimed at enhanced educational and
economic wellbeing, and (3) social impact investment and microfinance as mechanisms for reducing barriers to women’s education and subsequent sustained economic engagement. The priority for
this program is to increase funding to attract and support scholars in Washington, DC.
The IOM Anniversary Fellows is a program created in 2005 to celebrate the 35th anniversary
of the IOM. The purpose of the program is to bring exceptional early-career faculty and scholars
to work on an IOM board and an IOM study, forum, or roundtable. Since the initiation of the program, a total of nine fellows have received the award. Three fellowships, the Norman F. Gant, M.D./
American Board of Obstetrics and Gynecology, the James C. Puffer, MD/American Board of Family
Medicine, and a Pharmacy Fellowship have or are in the process of being endowed in perpetuity. Two
fellowships are currently being sponsored by outside organizations for a period of 2 years each.
PROGRAM LISTING
55
A new program was launched in 2012 that is a collaboration between the IOM and the FDA
Center for Tobacco Products (CTP). The fellowship program aims to provide an opportunity for
mid-career professionals to gain experience and expertise to further define and develop the field
of regulatory science as it relates to the regulation of tobacco products and FDA’s new authorities
under the Family Smoking Prevention and Tobacco Control Act. This summer, three fellows were
chosen in a national competition and will be assigned to one of three offices within CTP for the full
fellowship year: the Office of Health Communication and Education, the Office of Policy, and the
Office of Science. In following years, the number of fellows will increase to place fellows in all six
CTP program offices.
Robert Wood Johnson Foundation Health Policy Fellows Advisory Board Roster
Gail L. Warden (Chair), Henry Ford Health System, Detroit, MI
Joseph Antos, American Enterprise Institute for Public Policy Research, Washington, DC
Kenneth B. Chance, Sr., University of Kentucky, College of Dentistry, Lexington
Linda Degutis, Centers for Disease Control and Prevention, Atlanta, GA
Susan Dentzer, Editor-in-Chief, Health Affairs, Bethesda, MD
David Durenberger, Chair, National Health Policy Institute, University of St. Thomas,
Minneapolis, MN
James R. Gavin III, Emory University School of Medicine, Atlanta, GA, and Healing Our
Village, Inc., Lanham, MD
Katie B. Horton, George Washington University, Washington, DC
Arthur L. Kellermann, Senior Principal Researcher, RAND Corporation, Arlington, VA
Peter Neumann, Tufts University School of Medicine, Boston, MA
Charles L. Rice, Uniformed Services University of the Health Sciences, Military Health Systems, Department of Defense, Bethesda, Maryland
Sara Rosenbaum, George Washington University, Washington, DC
Eduardo J. Sanchez, Blue Cross and Blue Shield of Texas, Richardson
Kenneth B. Wells, Professor in Residence, University of California, Los Angeles, School of
Public Health, Senior Scientist, RAND
Executive Office
Judith A. Salerno, M.D., M.S., Leonard D. Schaeffer Executive Officer
From time to time, cross-cutting program activities are carried out within the IOM executive office,
such as the Roundtable on Value & Science-Driven Health Care and the Robert Wood Johnson
56
PRESIDENT’S REPORT SUPPLEMENT
Foundation Initiative on the Future of Nursing, at the Institute of Medicine. Some activities require
the expertise of IOM colleagues from several areas in the organization. This year, several activities
were continued and new, exciting initiatives were launched from the executive office.
Current Activities/Studies in Progress
• Vaccines: Cultural Representations in Art, Literature, Media and Public Health
• Gustav O. Lienhard Award
• The Rhoda and Bernard Sarnat International Prize in Mental Health
• Richard and Hinda Rosenthal Lecture Series
• End of Life Matters: Through the Eyes of Entertainment Arts
• The Weight of the Nation, with Home Box Office (HBO), the Centers for Disease Control and
Prevention, the National Institutes of Health, the Michael & Susan Dell Foundation, and Kaiser Permanente
• The Health Data Initiative
• Go Viral to Improve Health: IOM-NAE Health Data Collegiate Challenge
• Compassion in Caring: The Case for Transforming End-of-Life Care
• Roundtable on Value & Science-Driven Health Care
Art Installation at the 2011 IOM Annual Meeting (October 2011)
Literature, art, film, and mass media all influence the public’s understanding of epidemics and the
effectiveness of medicine’s responses. During the 2011 IOM Annual Meeting, Vaccines: Cultural
Representations in Arts and Literature was unveiled as a semiotic representation of how all types of
representations affect public perception and, ultimately, pubic utilization of vaccines. The support
of Janssen, a pharmaceutical company of Johnson & Johnson, made the installation possible. Copies of the installation were distributed to meeting attendees with their registration materials.
The Weight of the Nation Project (May 2012)
An opportunity to impact a national health epidemic through research, outreach, and print and
visual media does not come along often. When the opportunity to move the needle related to overweight and obesity in the United States presented itself, the IOM, along with HBO Documentary
Films, in association with the CDC and the NIH, and in partnership with the Michael & Susan Dell
Foundation and Kaiser Permanente, came together to produce The Weight of the Nation. The project features a series of four, Emmy-nominated films, a three-part HBO family film series, 14 bonus
short films, and an interactive social media campaign. A cornerstone of the project is the IOM
Food and Nutrition Board report released in April 2012, Accelerating Progress in Obesity Prevention.
Materials have been distributed around the country free of charge in an effort to drive outreach to
community-based organizations. The films and the report have launched considerable discussion
and ignited grassroots action around how individuals and communities can reverse the obesity
trend in the nation.
PROGRAM LISTING
57
To extend the outreach to focus on the epidemic in children, the executive office will spearhead the development of children’s publications on the overweight and obesity topic. Publications
will be geared to school-aged children in grades 3-5 and grades 6-8 with a particular emphasis on
Title I schools and underserved populations.
The Health Data Initiative (June 2012)
For the third consecutive year, the IOM, in collaboration with HHS and members of the Health
Data Consortium, hosted the Health Data Initiative (HDI) Forum III: The Health Datapalooza on
June 5–6, 2012, at the Walter E. Washington Convention Center in Washington, DC. Switching to
a 2-day format to accommodate 16 breakout discussion panels, 75 exhibitors, and more than 30
apps demonstrations, the Datapalooza attracted more than 1,450 attendees enthused about innovative ways to use de-identified health information. The forum featured announcements, awards,
demonstrations, meet-ups, and networking all focused on the potential to improve health by using
data.
The IOM has been integral in the formation of the Health Data Consortium, a collaboration
among government, nonprofit, and private-sector organizations working to foster the availability
and innovative use of data to improve health and health care. While still in its planning stage, the
consortium advocates for best practices and information sharing in health data; and works with
businesses, entrepreneurs, and academia to help them understand how to use data to develop new
products, services, apps, and research insights.
Go Viral to Improve Health (June 2012)
The IOM and the NAE challenged college and university students to use health data to develop
effective, innovative apps that take on the nation’s pressing health issues in the 2012 Go Viral to
Improve Health Data Collegiate Challenge. Working in interdisciplinary teams that brought
together technological skills and health knowledge, the IOM and NAE challenged college students
to generate exciting and powerful new products – the next “viral” apps – to improve health for
communities and individuals. In this the second year of the challenge, twice as many submissions
were received, and the products were of a high caliber. A team of students from Baylor College of
Medicine, University of Texas School of Public Health, and Rice University earned the first-place
award, while teams from Rose-Hulman Institute of Technology and Indiana University placed second and third, respectively. While the IOM and NAE contributed their resources to the challenge,
Heritage Provider Network provided the $10,000 award to the first-place team.
End-of-Life Care Activities in the Executive Office (Ongoing)
Continuing the national dialogue on end-of-life issues and interest stemming from the publication of the report Approaching Death: Improving Care at the End of Life, the executive office will
examine critical questions that individuals and families face at the end of life. Whether dealing
with a long-term illness or an unforeseen medical life-threatening event, questions such as “What
are your care preferences? How would you like to live your remaining life? Where do you prefer
to die?” often go unanswered. The IOM will commence a study, Compassion in Caring: The Case
58
PRESIDENT’S REPORT SUPPLEMENT
for Transforming End-of-Life Care (working title), to examine the policies necessary to align endof-life care with individual values and preferences, and assess the challenges and opportunities in
integrating end-of-life care into a patient- and family-centered, team-based framework of health
and community care. The work of this study will stimulate a national conversation with individuals, families, and communities on improving the way we, as a nation, approach death.
Roundtable on Value & Science-Driven Health Care
J. Michael McGinnis, M.D., M.P.P., Executive Director
The Roundtable on Value & Science-Driven Health Care provides a trusted venue for national leaders in health care to work cooperatively toward their common commitment to effective, innovative health care that consistently adds value to patients and society. Members include clinicians,
patients, health care organizations, employers, manufacturers, insurers, members of the health
information technology field, researchers, and policy makers. Together, they seek “the development of a learning health care system that is designed to generate and apply the best evidence for
the collaborative health care choices of each patient and provider; to drive the process of discovery
as a natural outgrowth of patient care; and to ensure innovation, quality, safety, and value in health
care.”
As leaders in their fields, roundtable members work with their colleagues to identify and
engage the key challenges and opportunities for achieving better outcomes and greater value in
health care. They then marshal the energy and resources of their respective sectors to work for
sustained public–private cooperation. The work of the roundtable is conducted through two types
of activities:
1. Identification and discussion of priorities in achieving the vision of a continuously learning
health system.
2. Fostering action through joint stakeholder projects stewarded through six Innovation Collaboratives focused on best clinical practices, communication of medical evidence, clinical
effectiveness research, digital technology for health, incentives for value in health care, and
systems reengineering for health ( jointly with the National Academy of Engineering).
Recent Reports and Discussion Papers
2012
• Digital Data Improvement Priorities for Continuous Learning in Health and Health Care –
Workshop Summary
• Best Care at Lower Cost: The Path to Continuously Learning Health Care in America
• “A CEO Checklist for High-Value Health Care” – Discussion Paper
• “Demanding Value from Our Health Care: Motivating Patient Action to Reduce Waste in
Health Care” – Discussion Paper
PROGRAM LISTING
59
2011
• “Patient-Clinician Communication: Basic Principles and Expectations” – Discussion
Paper
• “The Common Rule and Continuous Improvement in Health Care: A Learning Health
System Perspective” – Discussion Paper
Commentaries
• George Halvorson, MBA – “Walking Our Way to Better Health”
• Donna Shalala, PhD – “Free Employee Flu Shots Pay Prevention Dividends”
• Sheri McCoy, MSc, MBA – “Innovating to Improve Care and Manage Costs”
• Leonard Schaeffer and Dana Goldman, PhD – “Benefit Design Should Reflect Value”
• Mark Chassin, MD, MPP, MPH - “Taking Aim at the Right Targets”
• Senator Tom Daschle – “Controlling Costs: A Distinction and Our Choice”
• Robert Petzel, MD – “Surgical Complexity Initiative”
• Rich Umbdenstock – “Continuous Adoption of Best Practices-The New Normal”
• Bruce Bodaken, MPhil, – “A Path to Accountable Care”
• David Feinberg, MD, Molly Coye, MD, and Eugene Washington, MD – “Healing Humankind
One Patient at a Time”
• Steven Schroeder, MD – “Trying to Practice What I Preached: Helping My Parents at the
End of Their Lives”
• William Bornstein, MD, PhD and Michael Johns, MD – “Care Transformation at Emory
Healthcare”
• Paul Grundy, MD, MPH – “Bringing Knowledge Home”
• Farzad Mostashari, MD, ScM – “Applying Innovation to the Work of Government”
• Janet Corrigan, PhD, and Thomas Valuck, MD, JD – “A Glide Path to High-Value Health
Care”
• John Halamka, MD, MS – “Our Learning Health Care System Journey”
• Patrica Gabow, MD – “The Promise of Lean Processes”
• Helen Darling, MA – “Improving ROI in Health Care”
Innovation Collaboratives
• Best Practices Innovation Collaborative: Health professionals working together for evidencebased best practices
• Clinical Effectiveness Research Innovation Collaborative: Developing innovative approaches
to generate evidence for health care decisions
60
PRESIDENT’S REPORT SUPPLEMENT
• Digital Learning Collaborative: Advancing progress on creating the digital infrastructure
required for continuous improvement and innovation in health care
• Evidence Communication Innovation Collaborative: Exploring strategies for communicating
with patients about health care decisionmaking
• Value Incentives Learning Collaborative: Designing and evaluating innovations that reward
improved health outcomes while lowering costs
• Systems Engineering for Best Care: Applying lessons from engineering principles to lay the
foundations for a continuously learning health system with better care at lower costs
Projects in Development
• Workshop: Large Simple Trials and Knowledge Generation in a Learning System
• Workshop: Core Metrics for Better Care, Lower Costs, and Better Health
• Workshop: Driving Patient Demand for Informed Decisions, Better Value, and an Improving
System
• Workshop Summary: Digital Data Priorities for Continuous Learning in Health and Health
Care
• Commentaries
• Discussion Paper: “Harmonizing Reporting on Potential Conflicts of Interest: A Common
Disclosure Process for Health Care & Life Sciences”
• Discussion Paper: “Core Principles & Values of Effective Team-Based Health Care”
• Discussion Paper: “Communicating with Patients on Health Care Evidence”
• Discussion Paper: “Learning What Works Best in Health Care (2012 Update)”
• Discussion Paper: “Speeding the Movement of Successful Value Pilots to Effective
Practice”
• Discussion Paper: “Institutional Return on Information from the Digital Infrastructure”
• Discussion Paper: “Making the Case to Stakeholders for Continuous Improvement from
Routinely Collected Data”
Office of Reports and Communications
Clyde Behney, Deputy Executive Officer
Lauren Tobias, Communications Director
The IOM Office of Reports and Communication (ORAC) is responsible for the IOM’s report review
function, communications strategies and activities, and other functions related to the report process and the administration of the IOM.
PROGRAM LISTING
61
The communications aspect of ORAC’s role has two primary objectives: to increase public
understanding about who the IOM is and what it does, and to communicate effectively the substantive messages of the IOM’s studies and programs.
ORAC provides leadership, coordination, counsel, and assistance in the development of
strategies, products, and services that will enhance the communication and dissemination of IOM
reports and collateral materials. ORAC also administers the Kellogg Health of the Public Fund, an
endowment intended to better inform the public and local public health decision makers and to
develop targeted health resources, intervention strategies, and communication activities that are
responsive to the needs of local communities, especially underserved and disadvantaged communities. Additionally, ORAC manages the IOM’s e-mail marketing—including a monthly electronic
newsletter that reaches more than 38,000 people—and is responsible for Informing the Future:
Critical Issues in Health, which provides an overview of the IOM and its impact.
Ongoing Activities
Kellogg Health of the Public Fund
The Kellogg Health of the Public Fund is an endowed fund intended to increase the IOM’s impact
in its efforts to improve health by better informing the public and local public health decision makers about key health topics, as well as by developing targeted health resources and communication activities that are responsive to the needs of local communities—particularly underserved
and disadvantaged communities. Over the past 6 years, since the endowment began distributing
funds, the IOM has undertaken numerous activities, extending the work of IOM reports including
Health Literacy: A Prescription to End Confusion and Food Marketing to Children and Youth: Threat
or Opportunity?.
This year, the IOM has focused on a diverse set of topics and audiences to carry out the mission of this fund. To reach the general public with messages about the debilitating disease epilepsy,
the IOM developed a short online quiz based on the IOM’s March 2012 report Epilepsy Across the
Spectrum. The quiz was posted on the IOM website and shared with the more than 20 sponsors of
the report to help increase exposure and drive traffic to the report.
As the IOM looks to reach new audiences, one project currently under way targets Hispanic
women—particularly Mexican American women—with messages from the 2009 report Weight
Gain During Pregnancy: Reexamining the Guidelines. The project goal is to ensure that Mexican
American women understand the appropriate amount of weight to gain during pregnancy to be
healthy and ensure a healthy baby. The IOM is working with a number of partners to help spread
this message, as well as developing a number of user-friendly tools designed to highlight information from the report.
The IOM also is extending a program it launched in 2008, called Smart Bites. This program
provides incentives for youth to make healthier food choices when dining out by enlisting local
restaurants to discount healthy food and beverage items and promote these discounts to students.
Building on the success of the pilot program in Bowling Green, Kentucky, the IOM is poised to
expand the program into new communities across the United States.
These projects not only afford the IOM new opportunities to make an impact, they also grant
us the ability to see how our work makes a difference at the community level.
IOM FINANCES
63
Institute of Medicine Finances
A general overview of the IOM’s finances is illustrated in the materials that follow.
Chart 1 shows the IOM’s program expenditures over the last several years. Direct program
expenditures for fiscal year 2012 are estimated at just over $44 million, representing a decrease
from fiscal year 2011. We have experienced a sizable increase in our flow-thru program expenditures due to a number of large subcontracts. Our ratio of general operation expenditures to total
expenditures remains well below 20 percent. Table 1 presents the detailed dollar expenditures.
Sources of funding for general operations and program expenditures for fiscal year 2011 are
shown on Charts 2 and 3. The major sources of general operations support remain the indirect cost
pool of the National Research Council and income earned from the IOM endowment funds. As in
the past, the federal government continues as the main source of program support, providing 78
percent of the funds.
$‐
$10,000,000 $20,000,000 $30,000,000 $40,000,000 $50,000,000 $60,000,000 FY 2008
FY 2009
FY 2010
FY 2011
Chart 1
Program Expenditures
Fiscal Years 2008 through 2012
Est FY 2012
Direct Program
Flow‐Thru Program
64
PRESIDENT’S REPORT SUPPLEMENT
$
TOTAL IOM EXPENDITURES
$
$
146
19%
TOTAL
% General Operations to Total
118
Program
19%
168
136
32
FY 2009
FY 2008
Actual
45,565,850 $
38,828,893 $
15%
28
$
37,309,328 $
1,519,565
6,736,957
$
Actual
4,894,522
1,842,435
FY 2009
16%
38,294,484 $
32,095,812 $
29,919,694 $
2,176,118
6,198,672
4,531,785
1,666,887
General Operations
STAFF SIZE @ DEC (FTE'S)
% General Operations to Total
$
$
Direct Program
Flow-Thru Program
PROGRAM EXPENDITURES
$
$
TOTAL GENERAL OPERATIONS
NAS Indirect Cost Pool
IOM Independent Funds
GENERAL OPERATIONS
FY 2008
$
$
17%
187
156
31
FY 2010
13%
50,225,189 $
43,456,967 $
41,556,245 $
1,890,722
6,768,222
5,179,449
1,588,773
FY 2010
General Operations and Program Expenditures
Fiscal Years 2008 through 2012
Table 1
$
$
16%
214
180
34
FY 2011
11%
62,161,404 $
55,597,325 $
48,879,478 $
2,691,475
6,564,079
5,562,353
1,001,726
FY 2011
16%
200
168
32
FY 2012
Estimated
12%
64,077,007
56,560,477
44,019,508
12,540,969
7,516,530
5,852,583
1,663,947
FY 2012
Estimated
IOM FINANCES
65
Indirect Funds
85%
Chart 2
General Operations Support
Fiscal Year 2011
Total Budget $6,564,079
IOM Endowment Income
15%
66
PRESIDENT’S REPORT SUPPLEMENT
Private
21%
IOM
1%
Federal
78%
DHS
1%
VA
6% USDA
1%
Chart 3
Sources of Program Funding
Fiscal Year 2011
Total Budget @ $51,570,953
STATE
6%
DHHS
52%
Other
Federal
2%
DOD
10%
IOM FINANCES
67
Total Endowment
IOM Reserve
Leonard D. Schaeffer Endowment
Total Restricted
$
31,070,579
19,176,793
500,000
-
650,500
750,000
Norman F. Gant/ABOG Fellowship Fund
James C. Puffer/ABFM Fellowship Fund
$
62,250
5,000
Rosenthal Lecture Program
1,000,000
1,009,179
Sarnat Award Endowment
Sandra H. Matthews Cecil
-
1,200,000
Lienhard Award Endowment
1,367,080
1,349,405
-
1,000,000
76,000
-
-
-
-
1,010,775
David and Beatrix Hamburg Endowment Fund
211,055
-
-
-
100
-
-
17,675
17,675
-
-
7,359,489
$
$
$
$
Kellogg Health and Matching Grant
20,000
125,000
4,950
525,350
5,000,000
11,893,786
16,550
$
$
$
5,000,000
488,485
5,000,000
1,119,507
259,448
26,346
Women's Health Issues
Total Unrestricted
$
To 12/31/10
IOM Scholar in Residence Fund
Corporations
Members
Kaiser Family Foundation
Food & Nutrition Board:
Howard Hughes Medical Institute
Restricted Funds
Robert Wood Johnson Foundation
Kaiser Family Foundation
MacArthur Foundation
IOM Members
Pharmaceutical Companies
Miscellaneous Private Sector
Unrestricted Funds
SOURCE
CONTRIBUTIONS
To 12/31/11
$
$
$
$
$
32,437,659
20,526,198
500,000
1,000,000
826,000
650,500
1,000,000
67,250
1,009,179
1,200,000
1,010,775
7,570,544
20,000
16,550
125,000
5,050
525,350
5,000,000
11,911,461
5,000,000
488,485
5,000,000
1,137,182
259,448
26,346
TOTAL
ENDOWMENT FUNDS
Total Contributions and Market Value
December 31, 2011
INSTITUTE OF MEDICINE
$
$
$
$
$
64,428,601
38,801,070
955,026
876,352
852,602
1,539,345
5,305
1,518,245
4,425,147
1,368,422
9,523,297
85,825
74,239
470,688
26,358
1,628,285
15,451,934
25,627,531
11,174,017
871,805
11,087,030
1,903,523
528,839
62,316
$
$
$
$
$
60,346,138
37,263,769
896,558
893,355
892,806
789,467
1,393,321
62,046
1389584.9
4,089,892
1,285,716
9,115,685
80,877
69,693
441,870
24,832
1,528,598
14,309,469
23,082,370
10,052,976
784,338
9,983,923
1,729,278
475,792
56,063
MARKET VALUE
@ 12/31/10
@ 12/31/11
-6.3%
% MARKET
Change
'10 TO '11
68
PRESIDENT’S REPORT SUPPLEMENT
69
DONORS AND SPONSORS
2012 Private Contributions
We gratefully acknowledge the support of private contributors to the Institute of
Medicine. The collective, private philanthropy of our members and friends helps to
enhance the IOM’s impact as adviser to the nation on health.
The Einstein Society
In recognition of members and friends who have made lifetime contributions of $100,000 or more
to the National Academies as personal gifts or as gifts facilitated by the donor through a donor
advised fund, matching gift program, or family foundation. The following list reflects contributions
received as of August 31, 2012.
Anonymous
Lewis M. Branscomba
John Abelson
Donald L. Bren
Bruce and Betty Alberts
Sydney Brennera
Rose-Marie and Jack R. Anderson
George* and Virginia Bugliarello
John and Lise Armstrong
Malin Burnham
Richard C.a and Rita Atkinson
Russell L. Carson
Norman R. Augustine
Ralph J. and Carol M. Cicerone
Francisco and Hana Ayala
A. James Clark
William F. Ballhaus, Sr.
James McConnell Clark
Craig and Barbara Barrett
W. Dale and Jeanne Compton
Thomas D.* and Janice Hood Barrow
Roman W. DeSanctisa
Jordan* and Rhoda Baruch
Robert and Florence Deutsch
Warren L. Batts
Charles W. Duncan, Jr.
Stephen D. Bechtel, Jr.
George and Maggie Eads
Kenneth E. Behring
Robert and Cornelia Eaton
C. Gordon Bell
Harvey V. Fineberga and Mary E. Wilson
Elwyn and Jennifer Berlekamp
Michiko So* and Lawrence Finegold
Diane and Norman Bernstein
Tobie and Dan* Fink
Elkan R.a* and Gail Blout
George and Ann Fisher
David G. Bradley
Harold K.* and Betty A. Forsen
= IOM Member
* = Deceased
a
70
PRESIDENT’S REPORT SUPPLEMENT
William L. and Mary Kay Friend
Geralda and Doris Laubach
Eugene Garfield
David M. Lederman*
William H. Gates III
Whitney and Betty MacMillan
T. H. Geballe
Asad, Taj and Jamal Madni
Penny and Bill George
John F. McDonnell
Nan and Chuck Geschke
Robin K. and Rose M. McGuire
William T.* and Catherine Morrison
Golden
William W. McGuirea
Bernard M. Gordon
Richard and Ronay Menschel
Paul and Judy Gray
Jerome H. * and Barbara N. Grossman
a
Corbin Gwaltney
Margaret A. Hamburga and Peter F.
Brown
William M. Haney III
Michael and Sheila Held
Jane Hirsh
M. Blakeman Ingle
Joan and Irwin Mark Jacobs
Robert L. and Anne K. James
Anita K. Jones
Thomas V. Jones
Trevor O. Jones
Thomas Kailath
Yuet Waia and Alvera Kan
Fred Kavli
Cindy and Jeong Kim
Frederick A. Klingenstein
William I. Koch
Jill H. Kramer
John W. Landis
William W. Lang
= IOM Member
* = Deceased
a
Burton and DeeDee McMurtry
Dane and Mary Louise Miller
G. William* and Ariadna Miller
George P. Mitchell
Gordon and Betty Moore
Joe and Glenna Moore
David and Lindsay Morgenthaler
Richard M. Morrow
Philipa and Sima Needleman
Ralph S. O’Connor
Peter O’Donnell, Jr.
Charles* and Doris Pankow
Lawrence and Carol Papay
Jack S. Parker
Shela and Kumar Patel
Edward E. Penhoeta
Percy Pollard
Robert A.* and Mayari Pritzker
Allen E. and Marilyn Puckett
Ann and Michael Ramage
Simon Ramo
Carol and David Richards
Anne and Walt Robb
Henry M. Rowan
71
DONORS AND SPONSORS
George Rowe, Jr.
Edward C. Stone
Jack W. and Valerie Rowe
John and Janet Swanson
Joseph E.* and Anne P. Rowe
Judy Swanson
William J. Rutter
Charlotte and Morry Tanenbaum
Stephen and Anne Ryan
Peter and Vivian Teets
Jillian Sackler
Gary and Diane Tooker
Raymond and Beverly Sackler
Ted Turner
Henry and Susan Samueli
Leslie L. Vadasz
Bernard G.* and Rhoda Sarnat
Roya and Diana Vagelos
Maxine L. Savitz
Charles M. and Rebecca M. Vest
Leonard D. Schaeffera
Andrew and Erna Viterbi
Wendy and Eric Schmidt
Robert and Joan Wertheim
Sara Lee and Axel Schupf
John C. Whitehead
Melvin I. Simon
Wm. A. Wulf
Georges C. St. Laurent, Jr.
Alejandro Zaffaronia
Arnold and Constance Stancell
Janet and Jerry Zucker
a
a
Heritage Society
In recognition of members and friends for the thoughtful gesture of planning a gift today that provides for the future by including a bequest to the National Academies in their will or planning
another deferred gift. The following list reflects planned gift intentions as of August 31, 2012.
Andreas and Juana Acrivos
Clyde J. Behney
Gene M. and Marian Amdahl
Paul Berga
Betsy Ancker-Johnson
Franklin H. Blecher*
John C. Angus
Elkan R.a* and Gail F. Blout
John and Lise Armstrong
Enriqueta C. Bonda
Norman R. Augustine
Daniel Branton
W. O. Bakera*
Roberta and Lillian Brent
Jack D. Barchasa
Corale L. Brierley
Stanley Bauma
James A. Brierley
Stephen D. Bechtel, Jr.
Samuel Karlin* and Dorit Carmelli
= IOM Member
* = Deceased
a
72
PRESIDENT’S REPORT SUPPLEMENT
Rita K. Chowa
Richard B. Johnston, Jr.a
John A. Clements
Anita K. Jones
K. Danner Clouser *
Jerome Kagana
D. Walter Cohena
John W. Landis
Morrel H. Cohen
Norma M. Langa
Stanley N. Cohena
William W. Lang
Colleen Conway-Welcha
Edithe J. Levita*
Ross and Stephanie Corotis
R. Duncan* and Carolyn Luce
Ellis and Bettsy Cowling
Thomas S. Maddock
Molly J. Coyea
Artur Mager
a
Barbara J. Culliton
Jane Menkena
Malcolm R. Currie
Gordon and Betty Moore
Lee L. Davenport*
Arno G. Motulskya
Ruth M. Davis*
Van C.a and Barbara Mow
Robert A. Derzon*
Guido Munch
Peter N. Devreotes
Mary O. Mundingera
Paul M. Doty*
Philipa and Sima Needleman
a
Mildred S. Dresselhaus
Norman F. Ness
Merlin K. DuVal *
Ronald P. Nordgren
Ernest L.* and Eva Eliel
Gilbert S. Omenna
Gerard W. Elverum
William and Constance Opie
Emanuel Epstein
Bradford W. and Virginia W. Parkinson
William K. Estes*
Zack T. Pate
Tobie and Dan* Fink
Daniel W. Pettengilla*
Robert C. and Marilyn Forney
Frank Press
Paul H. Gilbert
Simon Ramo
Martin E. and Lucinda Glicksman
Alexander Richa
George Gloeckler
Henry W. Rieckena
Joseph W. Goodman
Emanuel P. Riversa
Chushiro* and Yoshiko Hayashi
Richard J. and Bonnie B. Robbins
Michael and Sheila Held
Doris E. Robertsa*
Thomas S. Inuia
James F. Roth
a
a
= IOM Member
* = Deceased
73
DONORS AND SPONSORS
Esther and Lewisa Rowland
Esther S. Takeuchi
Sheila A. Ryana
Paul Talalay
Paul R. Schimmel
Klaus D. Timmerhaus*
Stuart F. Schlossmana
Ivan M. Viest*
Rudia* and Sonja Schmid
Willis H. Ware
Kenneth I. Shinea
Robert H. and Joan Wertheim
Robert L. Sinsheimera
John Archibald* and Janette H. Wheeler
Arnold and Constance Stancell
Maw-Kuen Wu
H. Eugene Stanley
Wm. A. Wulf
a
Dale F. and Audrey Stein
Charles Yanofsky
Rosemary A. Stevens
Tilahun D. Yilma
John and Janet Swanson
Michael Zubkoffa
a
John A. Swets
IOM Society
In recognition of members of the Institute of Medicine who have made lifetime contributions of
$20,000 to $99,999 to the National Academies as personal gifts or as gifts facilitated by the donor
through a donor advised fund, matching gift program, or family foundation. The following list
reflects contributions received as of August 31, 2012.
a
Dyanne D. Affonso
Colleen Conway-Welch
Drew E. Altman
James F. Crow*
John R. Ball
Pedro M. Cuatrecasas
Jack D. Barchas
William H. Danforth
Paul Berg
Worth B. Daniels, Jr.*
Kenneth I. Berns
Delbert A. Fisher
Floyd E. Bloom
Richard L. Garwin
Robert and Lillian Brent
James R. Gavin III
Roger J. Bulger
Bradford H. Gray
Purnell W. Choppin
William N. Hubbard, Jr.
Mary Sue Coleman
Richard B. Johnston, Jr.
Barry and Bobbi Coller
Edithe J. Levit*
= IOM Member
* = Deceased
74
PRESIDENT’S REPORT SUPPLEMENT
Margaret E. Mahoney*
Rudi* and Sonja Schmid
Maclyn McCarty*
Phillip A. Sharp
J. Michael McGinnis
Kenneth I. Shine
Arno G. Motulsky
Eric M. Shooter
Van C. and Barbara Mow
Maxine F. Singer
Mary O. Mundinger
Robert L. Sinsheimer
Woodrow A. Myers, Jr.
Rosemary A. Stevens
Robert M. Nerem
Samuel O. Thier
Quigg Newton*
Robert E. Tranquada
Gilbert S. Omenn
Peter K. Vogt
June E. Osborn
Gail L. Warden
Daniel W. Pettengill*
Irving L. Weissman
Helen M. Ranney*
Torsten N. Wiesel
Alexander Rich
C. Kern Wildenthal
William C. Richardson
Jean D. Wilson
Henry W. Riecken
Tadataka Yamada
Sheila A. Ryan
Warren M. Zapol
Charles A. Sanders
Michael Zubkoff
Catalyst Society
In recognition of members and friends of the Institute of Medicine who contributed $10,000 or
more in collective support for the National Academies from September 1, 2011, to August 31, 2012.
We acknowledge those contributions made as personal gifts or as gifts facilitated by the donor
through a donor advised fund, matching gift program, or family foundation.
Members
Harvey V. Fineberg and Mary E. Wilson
Michael S. Gazzaniga
Avram Goldstein*
Richard B. Johnston, Jr.
Philip and Sima Needleman
* = Deceased
Stephen and Anne Ryan
Leonard D. Schaeffer
Phillip A. Sharp
Samuel O. Thier
75
DONORS AND SPONSORS
Friends
Anonymous
Russell L. Carson
Richard N. Foster
Penny and Bill George
George Rowe, Jr.
Judith A. Salerno
Judy Swanson
Jeff Tarr
Rosette Society
In recognition of members and friends of the Institute of Medicine who contributed between
$5,000 and $9,999 in collective support for the National Academies from September 1, 2011, to
August 31, 2012. We acknowledge those contributions made as personal gifts or as gifts facilitated
by the donor through a donor advised fund, matching gift program, or family foundation.
Members
Kenneth I. Berns
Lewis M. Branscomb
Stanley N. Cohen
Mary K. Estes
Fred H. Gage
Diane E. Griffin
Tony Hunter
Tadamitsu Kishimoto
J. Michael McGinnis
Maria Iandolo New
Marla E. Salmon
Nevin S. Scrimshaw
Robert L. Sinsheimer
Peter K. Vogt
Friend
Clara J. Szekely*
Challenge Society
In recognition of members and friends of the Institute of Medicine who contributed between
$2,500 and $4,999 in collective support for the National Academies from September 1, 2011, to
August 31, 2012. We acknowledge those contributions made as personal gifts or as gifts facilitated
by the donor through a donor advised fund, matching gift program, or family foundation.
Members
Dyanne D. Affonso
Maureen Bisognano
* = Deceased
Floyd E. Bloom
Purnell W. Choppin
76
PRESIDENT’S REPORT SUPPLEMENT
Ellen Wright Clayton
Bruce S. McEwen
K. Danner Clouser*
Ronald D. Miller
Fred E. Cohen
Edward E. Penhoet
Graham A. Colditz
John T. Potts, Jr.
Barry and Bobbi Coller
Larry J. Shapiro
William H. Danforth
Charles J. Sherr
Delbert A. Fisher
Harold C. Sox, Jr.
Sid Gilman
Joan A. Steitz
Robert Graham
Gail L. Warden
Caroline Breese Hall
James N. Weinstein
Jane E. Henney
Jean D. Wilson
Martha N. Hill
Warren M. Zapol
Gerald and Doris Laubach
Charter Society
In recognition of members and friends of the Institute of Medicine who contributed between
$1,000 and $2,499 in collective support for the National Academies from September 1, 2011, to
August 31, 2012. We acknowledge those contributions made as personal gifts or as gifts facilitated
by the donor through a donor advised fund, matching gift program, or family foundation.
Members
Francois M. Abboud
Nancy Adler and Arnold Milstein
Bobby R. Alford
Ron J. Anderson
Arthur K. Asbury
Anthony J. Atala
Dennis A. Ausiello
Jack D. Barchas
William G. Barsan
Arthur L. Beaudet
* = Deceased
Steven C. Beering
Robert J. Blendon
Barry R. Bloom
Enriqueta C. Bond
Jo Ivey Boufford
Murray F. Brennan
C. Thomas Caskey
David R. Challoner
D. Walter Cohen
Molly J. Coye
77
DONORS AND SPONSORS
Pedro M. Cuatrecasas
James S. and Judith M. Marks
Barbara J. Culliton
Elizabeth R. McAnarney
Philip D. Darney and Uta E. Landy
Angela Barron McBride
Susan Dentzer
Marie C. McCormick
Roman W. DeSanctis
Emmanuel Mignot and Servane Briand
Sue K. Donaldson
Mortimer Mishkin
R. Gordon Douglas, Jr.
Robert M. Nerem
Kathleen A. Dracup
John E. Niederhuber
Howard L. Fields
Paul A. Offit
Joseph J. Fins
Gilbert S. Omenn and Martha A. Darling
Donald E. Ganem
Suzanne Oparil
Norman F. Gant
Walter A. Orenstein
Gary L. Gottlieb
June E. Osborn
Antonio M. Gotto, Jr.
Herbert Pardes
M.R.C. Greenwood
Thomas D. Pollard
Ashley T. Haase
John Edward Porter
Jerris and Susan Hedges
Maximilian F. Reiser
Robert L. Hill
William C. Richardson
William N. Hubbard, Jr.
Emanuel P. Rivers
Thomas S. Inui
Vinod K. Sahney
Richard T. Johnson
Alan C. Sartorelli
Samuel L. Katz and Catherine M.
Wilfert
Donna E. Shalala
Sung Wan Kim
Aaron Shirley
David M. Kipnis
Edward A. Kravitz
Raju S. Kucherlapati
Judith R. Lave
Alan I. Leshner
Charles J. Lockwood
George D. Lundberg
JoAnn E. Manson
Michael L. Shelanski
Gerald I. Shulman
Maxine F. Singer
Jeanne C. Sinkford
William N. Spellacy
William and Janet Stead
Rosemary A. Stevens
Craig B. Thompson
James H. Thrall
78
PRESIDENT’S REPORT SUPPLEMENT
Reed V. Tuckson
James T. Willerson
Wylie Vale*
Owen N. Witte
Bailus Walker, Jr.
Tadataka Yamada
Cun-Yu Wang
Michael Zubkoff
A. Eugene Washington
Myrna M. Weissman
Friends
Thomas E. Wellems and Marilyn I.
Powell
Gordon Baym and Cathrine Blom
Nancy S. Wexler
Ellen M. Urbanski
Catherine M. Wilfert
Libo Fineberg
Other Individual Donors
In recognition of members and friends of the Institute of Medicine who contributed up to $999
in collective support for the National Academies from September 1, 2011, to August 31, 2012. We
acknowledge those contributions made as personal gifts or as gifts facilitated by the donor through
a donor advised fund, matching gift program, or family foundation.
Members
Anonymous
Karen H. Antman
Herbert L. Abrams
Kenneth J. Arrow
S. J. Adelstein
Ann M. Arvin
Margarita Alegria
David A. Asch
Paula G. Allen-Meares
Tom P. Aufderheide
Myron Allukian, Jr.
K. Frank Austen
Joel J. Alpert
W. Gerald Austen
Lawrence K. Altman
Joan K. Austin
Stuart H. Altman
Daniel L. Azarnoff
James M. Anderson
Howard L. Bailit
Kenneth C. Anderson
John R. Ball
Nancy C. Andreasen
Jeffrey R. Balser
Kathleen G. Andreoli
Clyde F. Barker
* = Deceased
79
DONORS AND SPONSORS
Jeremiah A. Barondess
Joseph A. Buckwalter
Elizabeth Barrett-Connor
Kathleen Coen Buckwalter
Eugene A. Bauer
Joseph A. Califano, Jr.
Bruce J. Baum
Charles C.J. Carpenter
John C. Beck
Benjamin S. Carson, Sr.
Richard E. Behrman
Webster K. Cavenee
Leslie Z. Benet
Martin Chalfie
Georges C. Benjamin
Leighton Chan
Ruth L. Berkelman
Cyril Chantler
Lionel M. Bernstein
Lincoln C. Chen
Eula Bingham
Michael E. Chernew
John D. Birkmeyer
Frank A. Chervenak
Michelle H. Biros
Zang-Hee Cho
Mina J. Bissell
Rita K. Chow
Robert E. Black
George P. Chrousos
Dan G. Blazer
Larry R. Churchill
R. Don Blim
David A. Clayton
Clara D. Bloomfield
Linda Hawes Clever
Stuart Bondurant
Jewel Plummer Cobb
Richard J. Bonnie
Mary Sue Coleman
Else Borst-Eilers
Jack M. Colwill
William H. Bowen
Colleen Conway-Welch
L. Thompson Bowles
Joel D. Cooper
Paula A. Braveman
Lisa A. Cooper
Rachel and Henry Brem
Max D. Cooper
Patricia F. Brennan
Lawrence Corey
Robert and Lillian Brent
Mark Cullen and Michele Barry
Norman E. Breslow
Susan J. Curry
William R. and Shirley Brinkley
George Q. Daley
Ralph L. Brinster
Nancy E. Davidson
Claire V. Broome
Karen Davis
Bruce G. Buchanan
Ciro de Quadros
80
PRESIDENT’S REPORT SUPPLEMENT
Alan H. DeCherney
Dennis G. Fryback
Patrick H. DeLeon
Victor R. Fuchs
Joel A. DeLisa
Elena Fuentes-Afflick
Ronald A. DePinho
Margaret T. Fuller
Peter B. Dervan
Terry T. Fulmer
Robert J. Desnick
Mitchell H. Gail
Don E. Detmer
E. John Gallagher
Luis A. Diaz
Theodore G. Ganiats
William H. Dietz
Patricia A. Ganz
Salvatore DiMauro
Joe G. Garcia
Jack E. Dixon
Atul Gawande
Deborah A. Driscoll
Helene D. Gayle
Mitzi L. Duxbury
Kristine M. Gebbie
Felton Earls and Maya Carlson
Apostolos Georgopoulos
Timothy Eberlein
John P. Geyman
Richard L. Ehman
Richard A. Gibbs
David and Lucy Eisenberg
David Ginsburg
Mickey S. Eisenberg
Alfred L. Goldberg
Neil J. Elgee
Irving H. Goldberg
Alain C. Enthoven
Lewis R. Goldfrank
Robert M. Epstein
Enoch Gordis
Caswell A. Evans, Jr.
Leon Gordis
William E. Evans
Emil C. Gotschlich
Stefan S. Fajans
Patricia A. Grady
Harold J. Fallon
Joe W. Gray
Diana L. Farmer
Deborah Greenspan
Charles D. Flagle
John S. Greenspan
Lee A. Fleisher
Paul F. Griner
Daniel W. Foster
Ellen R. Gritz
Henry W. Foster, Jr.
Gerald N. Grob
James G. Fox
Michael Grossman
Joseph F. Fraumeni, Jr.
Fernando A. Guerra
81
DONORS AND SPONSORS
Laurie M. Gunter
Kurt J. Isselbacher
Walter Guralnick
James S. Jackson
Bernard Guyer
Richard J. Jackson
Beatrice H. Hahn
Richard Janeway
Charles B. Hammond
Alan and Helgi Jobe
Qide Han
Roger A. Johns
Richard W. Hanson
Timothy Johnson
Stephen W. Hargarten
Wolfgang K. Joklik
Charlene A. Harrington
Alexandra L. Joyner
James G. Haughton
Michael M. Kaback
Richard J. Havel
William G. Kaelin
Maxine Hayes
Roger D. Kamm
William R. Hazzard
Frederick S. Kaplan
Carol P. Herbert
Nancy Kass
Arthur L. Herbst
Jerome P. Kassirer
Howard H. Hiatt
Michael B. Kastan
Eve Higginbotham and Frank Williams
Sidney Katz*
Kurt Hirschhorn
Emmett B. Keeler
Rochelle Hirschhorn
Art Kellermann
Tomas Hokfelt
David A. Kindig
Jimmie C. Holland
Patricia A. King
Edward W. Holmes
Raynard S. Kington
Thomas F. Hornbein
Seymour J. Klebanoff
James S. House
Herbert D. Kleber
Peter M. Howley
Claude B. Klee
Jennifer L. Howse
Charles R. Kleeman
Hedvig Hricak
Richard D. Krugman
James M. Hughes
Casimir A. Kulikowski
Barbara S. Hulka
David J. Kupfer
Peter Barton Hutt
Nathan Kuppermann
Richard and Fleur Hynes
Norma M. Lang
Sharon K. Inouye
Joseph Larner
* = Deceased
82
PRESIDENT’S REPORT SUPPLEMENT
Joyce C. Lashof
Jane Menken
Cato T. Laurencin
Richard A. Merrill
Robert S. Lawrence
I. George Miller, Jr.
Wendy and Ted Lawrence
Richard T. Miyamoto
Mitchell A. Lazar
William C. Mobley
John Q. Trojanowski and Virginia Man-Yee
Lee
Harold L. Moses
Michael L. LeFevre
John H. Moxley III
Howard Leventhal
Susan L. Lindquist
Jennifer Lippincott-Schwartz
Iris F. Litt
Jay S. Loeffler
Irving M. London
Jerold F. Lucey
Ruth Macklin
Peter and Marlene MacLeish
Henri R. Manasse, Jr.
Vincent T. Marchesi
Alexander R. Margulis
Howard Markel
James D. Marks
Paul A. Marks
Robert R. Marshak
Barry and Adrienne Marshall
George M. Martin
Ricardo Martinez
Ida M. Martinson
Bettie Sue S. Masters
Charles A. McCallum
James O. McNamara
Afaf I. Meleis
Arno G. Motulsky
Fitzhugh Mullan
Suzanne P. Murphy
Robert F. Murray, Jr.
Carl F. Nathan
David G. Nathan
Eric J. Nestler
Liz and Ben Neufeld
Arthur W. Nienhuis
Elena and Stuart Nightingale
Ruth S. Nussenzweig
Godfrey P. Oakley
Charles P. O’Brien
Olufunmilayo F. Olopade
Joseph P. Ornato
Peter Orszag
Arthur B. Pardee
John A. Parrish
Ira H. Pastan
Robert E. Patricelli
Nicholas A. Peppas
Ora H. Pescovitz
Herbert B. Peterson
Christine Petit
Theodore L. Phillips
83
DONORS AND SPONSORS
Chester M. Pierce
Leona D. Samson
Jeffrey L. Platt
David Satcher
Peter J. Polverini
Peter T. Scardino
Claire Pomeroy
Jane G. Schaller
Michael I. Posner
Thomas C. Schelling
Deborah E. Powell
Joseph E. Scherger
Dominick P. Purpura
Gerold L. Schiebler
Thomas C. Quinn
Steven A. Schroeder
Daniel J. Rader and Carolyn C.
Matthew P. Scott
Cannuscio
Susan C. Scrimshaw
Amelie G. Ramirez
Terrence J. Sejnowski
E. Albert Reece
Donald W. Seldin
Robert D. Reischauer
Iris R. Shannon
Mary V. Relling
Eleanor B. Sheldon
Alexander Rich
George F. Sheldon
Charles C. Richardson
Henry R. Shinefield
David L. Rimoin*
Stephen M. Shortell
Neil J. Risch
Edward H. Shortliffe
John B. Robbins
Ira Shoulson
James M. Roberts
Paul A. Sieving
Saul A. Rosenberg
Samuel C. Silverstein
David Rosner
Jonathan S. Skinner
Diane Rowland
Carolyn W. Slayman
Esther and Lewis Rowland
James P. Smith
Janet D. Rowley
Louis Sokoloff
Edward Rubenstein
David H. Solomon
David R. Rubinow
Jeannette E. South-Paul
Abraham M. Rudolph
Robert D. Sparks
Erkki Ruoslahti
Joseph W. St. Geme III
David H. Sachs
John R. Stanley
William M. Sage
Donald M. Steinwachs
Bruce J. Sams
Judith S. Stern
* = Deceased
84
PRESIDENT’S REPORT SUPPLEMENT
Margaret G. Stineman
Paul C. Weiler
John D. Stobo
Sheldon Weinbaum
James E. Strain
Arthur Weiss
Robert Straus
Ralph Weissleder
Brian L. Strom
Michael J. Welch*
Judith L. Swain
Zena Werb
Megan Sykes
John B. West
Nancy J. Tarbell
Raymond P. White, Jr.
Gerald E. Thomson
Torsten N. Wiesel
William M. Tierney
Richard S. Wilbur
Robert E. Tranquada
Charles B. Wilson
Arthur C. Upton
Ruby L. Wilson
William A. Vega
Gerald N. Wogan
Abraham C. Verghese
Barbara L. Wolfe
Barbara Vickrey
Mary Woolley
Edward H. Wagner
Laurence R. Young
Edward E. Wallach
Huda Y. Zoghbi
Christopher T. Walsh
Kathryn C. Zoon
Diane W. Wara
George D. Zuidema
Kenneth E. Warner
Judith Wasserheit
Friend
Connie M. Weaver
Dustin Deeks
Tributes and Memorials
In recognition of gifts made in honor or in memory of Institute of Medicine members and friends
from September 1, 2011, to August 31, 2012. In Honor of Harvey V. Fineberg
In Honor of Richard B. Johnston, Jr.
Libo Fineberg
Godfrey P. Oakley
* = Deceased
85
DONORS AND SPONSORS
In Honor of New Section 1 Members
Anthony J. Atala, Carolyn Bertozzi, Mark
E. Davis, George Georgiou, and David A.
Tirrell
In Memory of Marshall Nirenberg
Myrna M. Weissman
Cato T. Laurencin
Foundations, Corporations, and Other Organizations
In recognition of foundations, corporations, and other organizations that made gifts and grants to
the IOM from September 1, 2011, to August 31, 2012.
Foundations
American Board of Pediatrics Foundation
America’s Health Insurance Plans
Foundation
The Bill & Melinda Gates Foundation
George Family Foundation
Herbst Family Foundation
Lance Armstrong Foundation
Jackson Medical Mall Foundation
The Arnold and Mabel Beckman
Foundation
The JCT Foundation
The Atlantic Philanthropies (USA)
The Robert Wood Johnson Foundation
Lillian and Robert Brent Fund
The Henry J. Kaiser Family Foundation
Burroughs Wellcome Fund
The Katz Family Foundation
The California Endowment
W. M. Keck Foundation
California HealthCare Foundation
W. K. Kellogg Foundation
The Carson Family Charitable Trust
China Medical Board
The Susan G. Komen Breast Cancer
Foundation
Abram and D. Walter Cohen Foundation
The Kresge Foundation
The Commonwealth Fund
Josiah Macy, Jr. Foundation
Community Foundation for Southeastern
Michigan
March of Dimes Birth Defects Foundation
Michael and Susan Dell Foundation
Miami Foundation
RG & AM Douglas Foundation
Missouri Foundation for Health
Doris Duke Charitable Foundation
The Ambrose Monell Foundation
East Bay Community Foundation
NATA Research & Education
Foundation
F. Felix Foundation
Foundation for Child Development
Jewish Healthcare Foundation
McKnight Brain Research Foundation
The David and Lucile Packard
Foundation
86
PRESIDENT’S REPORT SUPPLEMENT
The Robert & Margaret Patricelli Family
Foundation, Inc.
The Seattle Foundation
SCAN Foundation
The Clara J. Szekely Foundation, Inc.
Solomon Family Trust
Corporations
Abbott Laboratories
Aetna Foundation
Aetna, Inc.
Amgen, Inc.
Anheuser-Busch InBev
AstraZeneca Pharmaceuticals LP
Avon Products Foundation, Inc.
Bessemer Trust
Blue Shield of California Foundation
Bristol-Myers Squibb Company
Cargill, Inc.
The Coca-Cola Company
Colgate-Palmolive Company
Computer Sciences Corporation
Duke Corporation
Eli Lilly and Company
Epic
ExxonMobil Foundation
Fidelity Charitable Gift Fund
GE Healthcare
GlaxoSmithKline
Holland & Knight Charitable Foundation,
Inc.
Humana, Inc.
Janssen Pharmaceutica Inc.
Johnson & Johnson
Kaiser Permanente
Kellogg Company
Kraft Foods, Inc.
Life Technologies, Inc.
Merck & Company, Inc.
Merck Partnership for Giving
Monsanto Company
Novartis Pharmaceuticals Corporation
Optuminsight, Inc.
Outcome Sciences, Inc.
Partners HealthCare Systems, Inc.
PepsiCo, Inc.
Pfizer Foundation Matching Gifts
Program
Pfizer, Inc.
Premier
Qualcomm, Inc.
Sanofi-Aventis
Sanofi Pasteur
Schwab Charitable Fund
Target Corporation
UBC Health Care Analytics, Inc.
United Health Foundation
United Healthcare
UnitedHealth Group, Inc.
University Physicians, Inc.
Wickizer Communications, Inc.
87
DONORS AND SPONSORS
Other Organizations
Academy Consortium for Complementary
& Alternative Health Care
Accreditation Council for Graduate
Medical Education
American College of Physicians
American College of Surgeons
American Dental Education
Association
American Diabetes Association
Alliance For Continuing Medical
Education
American Hospital Association
American Academy of Family
Physicians
American Nurses Association
American Academy of Nurse
Practitioners
American Psychological Association
American Association for Cancer
Research
American Association of Colleges of
Nursing
American Medical Association
American Nurses Credentialing Center
American Society for Microbiology
American Society for Radiation
Oncology
American Society of Clinical Oncology
American Association of Colleges of
Osteopathic Medicine
American Society of Hematology
American Association of Colleges of
Pharmacy
Arts Technology & Life Sciences
American Association of Nurse
Anesthetists
American Board of Family Medicine
American Board of Internal Medicine
The American Board of Obstetrics and
Gynecology
American Society of Human Genetics
Association of American Cancer
Institutes
Association of American Medical
Colleges
Association of American Veterinary
Medical Colleges
American Cancer Society, Inc.
Association of Schools of Allied Health
Professionals
American Chemistry Council
Association of Schools of Public Health
American College of Clinical Pharmacy
Catholic Health Initiatives
American College of Emergency
Physicians
C-Change
American College of Medical Genetics
The Critical Path Institute
American College of Nurse-Midwives
Dartmouth College
American College of Obstetricians &
Gynecologists
Duke University
CEO Roundtable on Cancer
88
PRESIDENT’S REPORT SUPPLEMENT
Environmental Systems Research
Institute
National Organization for Associate Degree
Nursing
Friends of Cancer Research
Oncology Nursing Society
Gay & Lesbian Medical Association
Parkland Health & Hospital System
Gerontological Society of America
PHI
HealthGrades, Inc.
Physician Assistant Education
Association
Infectious Diseases Society of America
National Academies of Practice
Ripple Effect Communications, Inc.
National Association of Chain Drug Stores
Foundation
Rutgers, The State University of New
Jersey
National Association of County and City
Health Officials
Society for Neuroscience
Society For Simulation in Healthcare
National Association of Emergency
Medical Technicians
Stanford University
National Coalition for Cancer
Survivorship
Tuberous Sclerosis Alliance
National Coalition for Health Professional
Education in Genetics
Stratasan, LLC
University of Southern California
VitalSpring Technologies
National League for Nursing, Inc.
We have made every effort to list donors accurately and according to their wishes. If we have made an
error, please accept our apologies and contact the development office at (202) 334-1342 so that we can
correct our records.
IN MEMORIAM
Institute of Medicine members whose deaths occurred since October 2011
John E. Affeldt
Mary Ellen Avery
Lester Breslow
James F. Crow
Paul M. Densen
Laurence E. Earley
William Campbell Felch
Robert J. Glaser
Avram Goldstein
Robert J. Joynt
Sidney Katz
Robert S. Ledley
Lawrence S. Lewin
Margaret E. Mahoney
Milnor B. Morrison
Lloyd J. Old
Gerald T. Perkoff
Curtis Prout
David L. Rimoin
F. Sherwood Rowland
Anne A. Scitovsky
Alvin J. Thompson
Wylie Vale
Michael J. Welch
T. Franklin Williams
Warren Winkelstein
89
500 Fifth Street, NW
Washington, DC 20001
TEL 202.334.2352
FAX 202.334.1412
www.iom.edu
The Institute of Medicine serves as adviser to the nation to improve health.
Established in 1970 as the health arm of the National Academy of Sciences,
the Institute of Medicine is a nonprofit organization that works outside of government
to provide unbiased and authoritative advice to decision makers and the public.